2016 Q2 Form 8-K Financial Statement
#000117992916000332 Filed on July 28, 2016
Income Statement
Concept | 2016 Q2 | 2015 Q2 | 2015 |
---|---|---|---|
Revenue | $4.359B | $3.525B | $14.18B |
YoY Change | 23.66% | 52.46% | 46.66% |
Cost Of Revenue | $3.710B | $2.962B | $11.99B |
YoY Change | 25.24% | 50.27% | 45.6% |
Gross Profit | $466.0M | $389.0M | $1.527B |
YoY Change | 19.79% | 14.21% | 52.7% |
Gross Profit Margin | 10.69% | 11.04% | 10.77% |
Selling, General & Admin | $510.0M | $421.8M | $1.700B |
YoY Change | 20.91% | 47.84% | 48.08% |
% of Gross Profit | 109.44% | 108.43% | 111.33% |
Research & Development | |||
YoY Change | |||
% of Gross Profit | |||
Depreciation & Amortization | $45.00M | $29.50M | $126.0M |
YoY Change | 52.54% | -9.79% | -5.97% |
% of Gross Profit | 9.66% | 7.58% | 8.25% |
Operating Expenses | $544.0M | $446.9M | $1.804B |
YoY Change | 21.73% | 45.0% | 45.37% |
Operating Profit | $105.0M | $116.0M | $387.0M |
YoY Change | -9.48% | 262.5% | 100.52% |
Interest Expense | $25.00M | $15.00M | $66.00M |
YoY Change | 66.67% | 7.2% | 15.79% |
% of Operating Profit | 23.81% | 12.93% | 17.05% |
Other Income/Expense, Net | -$25.00M | $15.00M | -$65.00M |
YoY Change | -266.67% | -207.27% | 12.07% |
Pretax Income | $80.00M | $101.0M | $322.0M |
YoY Change | -20.79% | 447.63% | 138.52% |
Income Tax | $47.00M | $62.00M | $179.0M |
% Of Pretax Income | 58.75% | 61.39% | 55.59% |
Net Earnings | $33.00M | $39.00M | $143.0M |
YoY Change | -15.38% | 387.5% | 130.65% |
Net Earnings / Revenue | 0.76% | 1.11% | 1.01% |
Basic Earnings Per Share | $0.58 | $0.78 | $2.75 |
Diluted Earnings Per Share | $0.58 | $0.72 | $2.58 |
COMMON SHARES | |||
Basic Shares Outstanding | 55.00M shares | 50.00M shares | 52.00M shares |
Diluted Shares Outstanding | 55.00M shares | 54.00M shares | 56.00M shares |
Balance Sheet
Concept | 2016 Q2 | 2015 Q2 | 2015 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $4.313B | $3.481B | $4.130B |
YoY Change | 23.92% | 96.84% | 61.45% |
Cash & Equivalents | $2.345B | $2.014B | $2.329B |
Short-Term Investments | $1.968B | $1.467B | $1.801B |
Other Short-Term Assets | $197.0M | $148.6M | $566.0M |
YoY Change | 32.56% | 58.33% | 1055.1% |
Inventory | |||
Prepaid Expenses | |||
Receivables | $1.012B | $631.1M | $597.0M |
Other Receivables | $23.00M | $0.00 | $13.00M |
Total Short-Term Assets | $5.545B | $4.806B | $5.306B |
YoY Change | 15.37% | 102.64% | 65.66% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $448.0M | $363.2M | $393.0M |
YoY Change | 23.33% | 14.36% | 15.25% |
Goodwill | $611.0M | $272.0M | |
YoY Change | 124.59% | 17.9% | |
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $39.00M | $37.81M | $236.0M |
YoY Change | 3.14% | -17.17% | -55.47% |
Total Long-Term Assets | $1.657B | $929.9M | $1.270B |
YoY Change | 78.19% | -13.91% | 3.08% |
TOTAL ASSETS | |||
Total Short-Term Assets | $5.545B | $4.806B | $5.306B |
Total Long-Term Assets | $1.657B | $929.9M | $1.270B |
Total Assets | $7.202B | $5.736B | $6.576B |
YoY Change | 25.55% | 66.17% | 48.28% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $537.0M | $399.2M | $362.0M |
YoY Change | 34.52% | -16.03% | 49.59% |
Accrued Expenses | |||
YoY Change | |||
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | $1.000M | $445.7M | $449.0M |
YoY Change | -99.78% | 140.32% | |
Total Short-Term Liabilities | $3.646B | $3.739B | $3.822B |
YoY Change | -2.47% | 129.23% | 75.72% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $1.626B | $474.3M | $1.160B |
YoY Change | 242.82% | -24.15% | 30.78% |
Other Long-Term Liabilities | $38.00M | $31.10M | $37.00M |
YoY Change | 22.21% | 8.27% | -89.81% |
Total Long-Term Liabilities | $1.664B | $31.10M | $1.197B |
YoY Change | 5251.34% | 8.27% | -4.24% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $3.646B | $3.739B | $3.822B |
Total Long-Term Liabilities | $1.664B | $31.10M | $1.197B |
Total Liabilities | $5.561B | $4.273B | $5.019B |
YoY Change | 30.14% | 68.56% | 46.54% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | $815.0M | $682.4M | |
YoY Change | 19.42% | 20.69% | |
Common Stock | $822.0M | $782.4M | |
YoY Change | 5.06% | 122.57% | |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $1.641B | $1.463B | $1.557B |
YoY Change | |||
Total Liabilities & Shareholders Equity | $7.202B | $5.736B | $6.576B |
YoY Change | 25.55% | 66.17% | 48.28% |
Cashflow Statement
Concept | 2016 Q2 | 2015 Q2 | 2015 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | $33.00M | $39.00M | $143.0M |
YoY Change | -15.38% | 387.5% | 130.65% |
Depreciation, Depletion And Amortization | $45.00M | $29.50M | $126.0M |
YoY Change | 52.54% | -9.79% | -5.97% |
Cash From Operating Activities | $139.0M | $94.10M | $1.125B |
YoY Change | 47.72% | 282.52% | 6.13% |
INVESTING ACTIVITIES | |||
Capital Expenditures | -$56.00M | -$40.90M | $132.0M |
YoY Change | 36.92% | 105.53% | 14.78% |
Acquisitions | $450.0M | ||
YoY Change | 922.73% | ||
Other Investing Activities | $97.00M | -$288.2M | $35.00M |
YoY Change | -133.66% | 424.0% | 52.17% |
Cash From Investing Activities | $41.00M | -$329.0M | -$1.420B |
YoY Change | -112.46% | 339.84% | 164.93% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | $373.0M | -$373.0M | |
YoY Change | |||
Debt Paid & Issued, Net | $0.00 | ||
YoY Change | |||
Cash From Financing Activities | 9.000M | 378.9M | $1.085B |
YoY Change | -97.62% | -6632.76% | 1273.42% |
NET CHANGE | |||
Cash From Operating Activities | 139.0M | 94.10M | $1.125B |
Cash From Investing Activities | 41.00M | -329.0M | -$1.420B |
Cash From Financing Activities | 9.000M | 378.9M | $1.085B |
Net Change In Cash | 189.0M | 144.0M | $790.0M |
YoY Change | 31.25% | -357.14% | 31.01% |
FREE CASH FLOW | |||
Cash From Operating Activities | $139.0M | $94.10M | $1.125B |
Capital Expenditures | -$56.00M | -$40.90M | $132.0M |
Free Cash Flow | $195.0M | $135.0M | $993.0M |
YoY Change | 44.44% | 203.37% | 5.08% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Document Type
DocumentType
|
8-K | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2016-07-28 | ||
CY2014Q4 | moh |
Anticipated Medicare Risk Adjustment Premiums
AnticipatedMedicareRiskAdjustmentPremiums
|
8000000 | USD |
CY2015Q4 | moh |
Anticipated Medicare Risk Adjustment Premiums
AnticipatedMedicareRiskAdjustmentPremiums
|
-4000000 | USD |
CY2016Q2 | moh |
Anticipated Medicare Risk Adjustment Premiums
AnticipatedMedicareRiskAdjustmentPremiums
|
19000000 | USD |
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001179929 | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
MOLINA HEALTHCARE INC | ||
CY2014Q4 | moh |
Affordable Care Act Premium Stabilization Program Minimum Medical Loss Ratio Receivable Payable
AffordableCareActPremiumStabilizationProgramMinimumMedicalLossRatioReceivablePayable
|
0 | USD |
CY2015Q4 | moh |
Affordable Care Act Premium Stabilization Program Minimum Medical Loss Ratio Receivable Payable
AffordableCareActPremiumStabilizationProgramMinimumMedicalLossRatioReceivablePayable
|
-3000000 | USD |
CY2016Q2 | moh |
Affordable Care Act Premium Stabilization Program Minimum Medical Loss Ratio Receivable Payable
AffordableCareActPremiumStabilizationProgramMinimumMedicalLossRatioReceivablePayable
|
-19000000 | USD |
CY2016Q2 | moh |
Affordable Care Act Premium Stabilization Program Minimum Medical Loss Ratio Receivable Payable Current Year
AffordableCareActPremiumStabilizationProgramMinimumMedicalLossRatioReceivablePayableCurrentYear
|
-17000000 | USD |
CY2016Q2 | moh |
Affordable Care Act Premium Stabilization Program Minimum Medical Loss Ratio Receivable Payable Prior Years
AffordableCareActPremiumStabilizationProgramMinimumMedicalLossRatioReceivablePayablePriorYears
|
-2000000 | USD |
CY2014Q4 | moh |
Affordable Care Act Premium Stabilization Program Reinsurance Receivable Payable
AffordableCareActPremiumStabilizationProgramReinsuranceReceivablePayable
|
5000000 | USD |
CY2015Q4 | moh |
Affordable Care Act Premium Stabilization Program Reinsurance Receivable Payable
AffordableCareActPremiumStabilizationProgramReinsuranceReceivablePayable
|
36000000 | USD |
CY2016Q2 | moh |
Affordable Care Act Premium Stabilization Program Reinsurance Receivable Payable
AffordableCareActPremiumStabilizationProgramReinsuranceReceivablePayable
|
81000000 | USD |
CY2016Q2 | moh |
Affordable Care Act Premium Stabilization Program Reinsurance Receivable Payable Current Year
AffordableCareActPremiumStabilizationProgramReinsuranceReceivablePayableCurrentYear
|
57000000 | USD |
CY2016Q2 | moh |
Affordable Care Act Premium Stabilization Program Reinsurance Receivable Payable Prior Years
AffordableCareActPremiumStabilizationProgramReinsuranceReceivablePayablePriorYears
|
24000000 | USD |
CY2014Q4 | moh |
Affordable Care Act Premium Stabilization Program Risk Adjustment Receivable Payable
AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivablePayable
|
-5000000 | USD |
CY2015Q4 | moh |
Affordable Care Act Premium Stabilization Program Risk Adjustment Receivable Payable
AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivablePayable
|
-214000000 | USD |
CY2016Q2 | moh |
Affordable Care Act Premium Stabilization Program Risk Adjustment Receivable Payable
AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivablePayable
|
-474000000 | USD |
CY2016Q2 | moh |
Affordable Care Act Premium Stabilization Program Risk Adjustment Receivable Payable Current Year
AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivablePayableCurrentYear
|
-220000000 | USD |
CY2016Q2 | moh |
Affordable Care Act Premium Stabilization Program Risk Adjustment Receivable Payable Prior Years
AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivablePayablePriorYears
|
-254000000 | USD |
CY2014Q4 | moh |
Affordable Care Act Premium Stabilization Program Risk Corridor Receivable Payable
AffordableCareActPremiumStabilizationProgramRiskCorridorReceivablePayable
|
0 | USD |
CY2015Q4 | moh |
Affordable Care Act Premium Stabilization Program Risk Corridor Receivable Payable
AffordableCareActPremiumStabilizationProgramRiskCorridorReceivablePayable
|
-10000000 | USD |
CY2016Q2 | moh |
Affordable Care Act Premium Stabilization Program Risk Corridor Receivable Payable
AffordableCareActPremiumStabilizationProgramRiskCorridorReceivablePayable
|
-12000000 | USD |
CY2016Q2 | moh |
Affordable Care Act Premium Stabilization Program Risk Corridor Receivable Payable Current Year
AffordableCareActPremiumStabilizationProgramRiskCorridorReceivablePayableCurrentYear
|
-9000000 | USD |
CY2016Q2 | moh |
Affordable Care Act Premium Stabilization Program Risk Corridor Receivable Payable Prior Years
AffordableCareActPremiumStabilizationProgramRiskCorridorReceivablePayablePriorYears
|
-3000000 | USD |
CY2013 | moh |
Amortizationof Debt Discount Premiumand Sale Leaseback Financing Obligation
AmortizationofDebtDiscountPremiumandSaleLeasebackFinancingObligation
|
23000000 | USD |
CY2014 | moh |
Amortizationof Debt Discount Premiumand Sale Leaseback Financing Obligation
AmortizationofDebtDiscountPremiumandSaleLeasebackFinancingObligation
|
27000000 | USD |
moh |
Amortizationof Debt Discount Premiumand Sale Leaseback Financing Obligation
AmortizationofDebtDiscountPremiumandSaleLeasebackFinancingObligation
|
15000000 | USD | |
CY2015 | moh |
Amortizationof Debt Discount Premiumand Sale Leaseback Financing Obligation
AmortizationofDebtDiscountPremiumandSaleLeasebackFinancingObligation
|
30000000 | USD |
moh |
Amortizationof Debt Discount Premiumand Sale Leaseback Financing Obligation
AmortizationofDebtDiscountPremiumandSaleLeasebackFinancingObligation
|
15000000 | USD | |
CY2013 | moh |
Business Combination Contingent Consideration Accrual
BusinessCombinationContingentConsiderationAccrual
|
60000000 | USD |
CY2014 | moh |
Business Combination Contingent Consideration Accrual
BusinessCombinationContingentConsiderationAccrual
|
0 | USD |
CY2015 | moh |
Business Combination Contingent Consideration Accrual
BusinessCombinationContingentConsiderationAccrual
|
0 | USD |
CY2013 | moh |
Business Combination Prepaid Consideration Transferred
BusinessCombinationPrepaidConsiderationTransferred
|
0 | USD |
CY2014 | moh |
Business Combination Prepaid Consideration Transferred
BusinessCombinationPrepaidConsiderationTransferred
|
0 | USD |
moh |
Business Combination Prepaid Consideration Transferred
BusinessCombinationPrepaidConsiderationTransferred
|
0 | USD | |
CY2015 | moh |
Business Combination Prepaid Consideration Transferred
BusinessCombinationPrepaidConsiderationTransferred
|
102000000 | USD |
moh |
Business Combination Prepaid Consideration Transferred
BusinessCombinationPrepaidConsiderationTransferred
|
-102000000 | USD | |
CY2013Q4 | moh |
Capitation Claims Payable
CapitationClaimsPayable
|
20000000 | USD |
CY2014Q4 | moh |
Capitation Claims Payable
CapitationClaimsPayable
|
28000000 | USD |
CY2015Q4 | moh |
Capitation Claims Payable
CapitationClaimsPayable
|
140000000 | USD |
CY2016Q2 | moh |
Capitation Claims Payable
CapitationClaimsPayable
|
37000000 | USD |
CY2015 | moh |
Class Of Warrant Or Right Threshold Percentage Of Stock Price Trigger
ClassOfWarrantOrRightThresholdPercentageOfStockPriceTrigger
|
0.00625 | |
CY2015 | moh |
Class Of Warrant Or Right Trading Days Measurement Period
ClassOfWarrantOrRightTradingDaysMeasurementPeriod
|
P160D | |
moh |
Class Of Warrant Or Right Trading Days Measurement Period
ClassOfWarrantOrRightTradingDaysMeasurementPeriod
|
P160D | ||
CY2015Q4 | moh |
Classof Warrantor Right Stated Percentage
ClassofWarrantorRightStatedPercentage
|
0.01125 | |
CY2016Q2 | moh |
Classof Warrantor Right Stated Percentage
ClassofWarrantorRightStatedPercentage
|
0.01125 | |
CY2013 | moh |
Cost Of Services Amortization Of Capitalized Software
CostOfServicesAmortizationOfCapitalizedSoftware
|
18000000 | USD |
CY2014 | moh |
Cost Of Services Amortization Of Capitalized Software
CostOfServicesAmortizationOfCapitalizedSoftware
|
38000000 | USD |
CY2015 | moh |
Cost Of Services Amortization Of Capitalized Software
CostOfServicesAmortizationOfCapitalizedSoftware
|
21000000 | USD |
CY2015 | moh |
Deferred Compensation Plan Deferral Percentage Of Basic Salary
DeferredCompensationPlanDeferralPercentageOfBasicSalary
|
1 | |
CY2015 | moh |
Deferred Compensation Plan Deferral Percentage Of Bonus
DeferredCompensationPlanDeferralPercentageOfBonus
|
1 | |
CY2013 | moh |
Depreciation And Amortization Of Capitalized Software
DepreciationAndAmortizationOfCapitalizedSoftware
|
55000000 | USD |
CY2014 | moh |
Depreciation And Amortization Of Capitalized Software
DepreciationAndAmortizationOfCapitalizedSoftware
|
75000000 | USD |
CY2015 | moh |
Depreciation And Amortization Of Capitalized Software
DepreciationAndAmortizationOfCapitalizedSoftware
|
87000000 | USD |
CY2013 | moh |
Depreciationand Amortization Continuing Operations
DepreciationandAmortizationContinuingOperations
|
73000000 | USD |
CY2014 | moh |
Depreciationand Amortization Continuing Operations
DepreciationandAmortizationContinuingOperations
|
93000000 | USD |
CY2015 | moh |
Depreciationand Amortization Continuing Operations
DepreciationandAmortizationContinuingOperations
|
104000000 | USD |
CY2013 | moh |
Effective Income Tax Rate Reconciliation Nondeductible Expense Health Insurance Percent
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseHealthInsurancePercent
|
0.000 | |
CY2014 | moh |
Effective Income Tax Rate Reconciliation Nondeductible Expense Health Insurance Percent
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseHealthInsurancePercent
|
0.229 | |
CY2015 | moh |
Effective Income Tax Rate Reconciliation Nondeductible Expense Health Insurance Percent
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseHealthInsurancePercent
|
0.170 | |
CY2013 | moh |
Effective Income Tax Rate Reconciliation Nondeductible Expense Warrants Percent
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseWarrantsPercent
|
0.024 | |
CY2014 | moh |
Effective Income Tax Rate Reconciliation Nondeductible Expense Warrants Percent
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseWarrantsPercent
|
0.000 | |
CY2015 | moh |
Effective Income Tax Rate Reconciliation Nondeductible Expense Warrants Percent
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseWarrantsPercent
|
0.000 | |
CY2013Q4 | moh |
Goodwill And Intangible Assets Net
GoodwillAndIntangibleAssetsNet
|
330000000 | USD |
CY2014Q4 | moh |
Goodwill And Intangible Assets Net
GoodwillAndIntangibleAssetsNet
|
361000000 | USD |
CY2015Q4 | moh |
Goodwill And Intangible Assets Net
GoodwillAndIntangibleAssetsNet
|
641000000 | USD |
CY2013 | moh |
Health Care Organization Direct Delivery Expense
HealthCareOrganizationDirectDeliveryExpense
|
48000000 | USD |
CY2014 | moh |
Health Care Organization Direct Delivery Expense
HealthCareOrganizationDirectDeliveryExpense
|
96000000 | USD |
CY2015 | moh |
Health Care Organization Direct Delivery Expense
HealthCareOrganizationDirectDeliveryExpense
|
128000000 | USD |
CY2013 | moh |
Health Care Organization Direct Delivery Expense Per Member Per Month
HealthCareOrganizationDirectDeliveryExpensePerMemberPerMonth
|
2.14 | |
CY2014 | moh |
Health Care Organization Direct Delivery Expense Per Member Per Month
HealthCareOrganizationDirectDeliveryExpensePerMemberPerMonth
|
3.44 | |
CY2015 | moh |
Health Care Organization Direct Delivery Expense Per Member Per Month
HealthCareOrganizationDirectDeliveryExpensePerMemberPerMonth
|
3.26 | |
CY2013 | moh |
Health Care Organization Expenses Capitation Costs
HealthCareOrganizationExpensesCapitationCosts
|
604000000 | USD |
CY2014 | moh |
Health Care Organization Expenses Capitation Costs
HealthCareOrganizationExpensesCapitationCosts
|
748000000 | USD |
CY2015 | moh |
Health Care Organization Expenses Capitation Costs
HealthCareOrganizationExpensesCapitationCosts
|
982000000 | USD |
CY2013 | moh |
Health Care Organization Expenses Capitation Costs Per Member Per Month
HealthCareOrganizationExpensesCapitationCostsPerMemberPerMonth
|
26.83 | |
CY2014 | moh |
Health Care Organization Expenses Capitation Costs Per Member Per Month
HealthCareOrganizationExpensesCapitationCostsPerMemberPerMonth
|
26.77 | |
CY2015 | moh |
Health Care Organization Expenses Capitation Costs Per Member Per Month
HealthCareOrganizationExpensesCapitationCostsPerMemberPerMonth
|
25.02 | |
CY2013 | moh |
Health Care Organization Expenses Gross Per Member Per Month
HealthCareOrganizationExpensesGrossPerMemberPerMonth
|
238.99 | |
CY2014 | moh |
Health Care Organization Expenses Gross Per Member Per Month
HealthCareOrganizationExpensesGrossPerMemberPerMonth
|
288.84 | |
CY2015 | moh |
Health Care Organization Expenses Gross Per Member Per Month
HealthCareOrganizationExpensesGrossPerMemberPerMonth
|
300.43 | |
CY2013 | moh |
Health Care Organization Expenses Other Costs
HealthCareOrganizationExpensesOtherCosts
|
181000000 | USD |
CY2014 | moh |
Health Care Organization Expenses Other Costs
HealthCareOrganizationExpensesOtherCosts
|
286000000 | USD |
CY2015 | moh |
Health Care Organization Expenses Other Costs
HealthCareOrganizationExpensesOtherCosts
|
502000000 | USD |
CY2013 | moh |
Health Care Organization Expenses Other Costs Per Member Per Month
HealthCareOrganizationExpensesOtherCostsPerMemberPerMonth
|
8.05 | |
CY2014 | moh |
Health Care Organization Expenses Other Costs Per Member Per Month
HealthCareOrganizationExpensesOtherCostsPerMemberPerMonth
|
10.22 | |
CY2015 | moh |
Health Care Organization Expenses Other Costs Per Member Per Month
HealthCareOrganizationExpensesOtherCostsPerMemberPerMonth
|
12.79 | |
CY2013 | moh |
Health Care Organization Expenses Servicing Cost
HealthCareOrganizationExpensesServicingCost
|
3612000000 | USD |
CY2014 | moh |
Health Care Organization Expenses Servicing Cost
HealthCareOrganizationExpensesServicingCost
|
5673000000 | USD |
CY2015 | moh |
Health Care Organization Expenses Servicing Cost
HealthCareOrganizationExpensesServicingCost
|
8572000000 | USD |
CY2013 | moh |
Health Care Organization Expenses Servicing Cost Per Member Per Month
HealthCareOrganizationExpensesServicingCostPerMemberPerMonth
|
160.43 | |
CY2014 | moh |
Health Care Organization Expenses Servicing Cost Per Member Per Month
HealthCareOrganizationExpensesServicingCostPerMemberPerMonth
|
202.87 | |
CY2015 | moh |
Health Care Organization Expenses Servicing Cost Per Member Per Month
HealthCareOrganizationExpensesServicingCostPerMemberPerMonth
|
218.35 | |
CY2013 | moh |
Health Care Organization Insurer Fee Expense
HealthCareOrganizationInsurerFeeExpense
|
0 | USD |
CY2014 | moh |
Health Care Organization Insurer Fee Expense
HealthCareOrganizationInsurerFeeExpense
|
89000000 | USD |
CY2015Q2 | moh |
Health Care Organization Insurer Fee Expense
HealthCareOrganizationInsurerFeeExpense
|
40000000 | USD |
moh |
Health Care Organization Insurer Fee Expense
HealthCareOrganizationInsurerFeeExpense
|
81000000 | USD | |
CY2015 | moh |
Health Care Organization Insurer Fee Expense
HealthCareOrganizationInsurerFeeExpense
|
157000000 | USD |
CY2016Q2 | moh |
Health Care Organization Insurer Fee Expense
HealthCareOrganizationInsurerFeeExpense
|
50000000 | USD |
moh |
Health Care Organization Insurer Fee Expense
HealthCareOrganizationInsurerFeeExpense
|
108000000 | USD | |
CY2013 | moh |
Health Care Organization Insurer Fee Revenue
HealthCareOrganizationInsurerFeeRevenue
|
0 | USD |
CY2014 | moh |
Health Care Organization Insurer Fee Revenue
HealthCareOrganizationInsurerFeeRevenue
|
120000000 | USD |
CY2015Q2 | moh |
Health Care Organization Insurer Fee Revenue
HealthCareOrganizationInsurerFeeRevenue
|
74000000 | USD |
moh |
Health Care Organization Insurer Fee Revenue
HealthCareOrganizationInsurerFeeRevenue
|
122000000 | USD | |
CY2015 | moh |
Health Care Organization Insurer Fee Revenue
HealthCareOrganizationInsurerFeeRevenue
|
264000000 | USD |
CY2016Q2 | moh |
Health Care Organization Insurer Fee Revenue
HealthCareOrganizationInsurerFeeRevenue
|
76000000 | USD |
moh |
Health Care Organization Insurer Fee Revenue
HealthCareOrganizationInsurerFeeRevenue
|
166000000 | USD | |
CY2013 | moh |
Health Care Organization Medical Suppliesand Drugs Expense Per Member Per Month
HealthCareOrganizationMedicalSuppliesandDrugsExpensePerMemberPerMonth
|
41.54 | |
CY2014 | moh |
Health Care Organization Medical Suppliesand Drugs Expense Per Member Per Month
HealthCareOrganizationMedicalSuppliesandDrugsExpensePerMemberPerMonth
|
45.54 | |
CY2015 | moh |
Health Care Organization Medical Suppliesand Drugs Expense Per Member Per Month
HealthCareOrganizationMedicalSuppliesandDrugsExpensePerMemberPerMonth
|
41.01 | |
CY2013 | moh |
Health Care Organization Premium Tax Revenue
HealthCareOrganizationPremiumTaxRevenue
|
172000000 | USD |
CY2014 | moh |
Health Care Organization Premium Tax Revenue
HealthCareOrganizationPremiumTaxRevenue
|
294000000 | USD |
CY2015Q2 | moh |
Health Care Organization Premium Tax Revenue
HealthCareOrganizationPremiumTaxRevenue
|
95000000 | USD |
moh |
Health Care Organization Premium Tax Revenue
HealthCareOrganizationPremiumTaxRevenue
|
190000000 | USD | |
CY2015 | moh |
Health Care Organization Premium Tax Revenue
HealthCareOrganizationPremiumTaxRevenue
|
397000000 | USD |
CY2016Q2 | moh |
Health Care Organization Premium Tax Revenue
HealthCareOrganizationPremiumTaxRevenue
|
109000000 | USD |
moh |
Health Care Organization Premium Tax Revenue
HealthCareOrganizationPremiumTaxRevenue
|
218000000 | USD | |
CY2013 | moh |
Increase Decreasein Medical Premium Liability Dueto Agency
IncreaseDecreaseinMedicalPremiumLiabilityDuetoAgency
|
28000000 | USD |
CY2014 | moh |
Increase Decreasein Medical Premium Liability Dueto Agency
IncreaseDecreaseinMedicalPremiumLiabilityDuetoAgency
|
470000000 | USD |
moh |
Increase Decreasein Medical Premium Liability Dueto Agency
IncreaseDecreaseinMedicalPremiumLiabilityDuetoAgency
|
298000000 | USD | |
CY2015 | moh |
Increase Decreasein Medical Premium Liability Dueto Agency
IncreaseDecreaseinMedicalPremiumLiabilityDuetoAgency
|
202000000 | USD |
moh |
Increase Decreasein Medical Premium Liability Dueto Agency
IncreaseDecreaseinMedicalPremiumLiabilityDuetoAgency
|
509000000 | USD | |
CY2015 | moh |
Investments Average Maturity Period
InvestmentsAverageMaturityPeriod
|
P3Y | |
CY2015 | moh |
Investments Maturity Period
InvestmentsMaturityPeriod
|
P10Y | |
CY2014Q4 | moh |
Lease Financing Obligations Noncurrent
LeaseFinancingObligationsNoncurrent
|
157000000 | USD |
CY2015Q4 | moh |
Lease Financing Obligations Noncurrent
LeaseFinancingObligationsNoncurrent
|
198000000 | USD |
CY2016Q2 | moh |
Lease Financing Obligations Noncurrent
LeaseFinancingObligationsNoncurrent
|
198000000 | USD |
CY2015 | moh |
Maturity Of Cash And Cash Equivalents
MaturityOfCashAndCashEquivalents
|
three months or less | |
CY2015 | moh |
Maximum Period For Member Risk Scores And Member Pharmacy Cost Experience After Original Year Of Service
MaximumPeriodForMemberRiskScoresAndMemberPharmacyCostExperienceAfterOriginalYearOfService
|
P2Y | |
CY2013 | moh |
Medical Administrative Costs
MedicalAdministrativeCosts
|
153000000 | USD |
CY2014 | moh |
Medical Administrative Costs
MedicalAdministrativeCosts
|
263000000 | USD |
CY2015 | moh |
Medical Administrative Costs
MedicalAdministrativeCosts
|
398000000 | USD |
CY2013Q4 | moh |
Medical Claimsand Benefits Payable
MedicalClaimsandBenefitsPayable
|
151000000 | USD |
CY2014Q4 | moh |
Medical Claimsand Benefits Payable
MedicalClaimsandBenefitsPayable
|
119000000 | USD |
CY2015Q4 | moh |
Medical Claimsand Benefits Payable
MedicalClaimsandBenefitsPayable
|
167000000 | USD |
CY2016Q2 | moh |
Medical Claimsand Benefits Payable
MedicalClaimsandBenefitsPayable
|
191000000 | USD |
CY2013 | moh |
Medical Claimsand Benefits Payable Adjustments Changein Provider
MedicalClaimsandBenefitsPayableAdjustmentsChangeinProvider
|
111000000 | USD |
CY2014 | moh |
Medical Claimsand Benefits Payable Adjustments Changein Provider
MedicalClaimsandBenefitsPayableAdjustmentsChangeinProvider
|
-32000000 | USD |
CY2015 | moh |
Medical Claimsand Benefits Payable Adjustments Changein Provider
MedicalClaimsandBenefitsPayableAdjustmentsChangeinProvider
|
48000000 | USD |
moh |
Medical Claimsand Benefits Payable Adjustments Changein Provider
MedicalClaimsandBenefitsPayableAdjustmentsChangeinProvider
|
24000000 | USD | |
CY2014Q4 | moh |
Medical Premium Liability Dueto Agency
MedicalPremiumLiabilityDuetoAgency
|
527000000 | USD |
CY2015Q4 | moh |
Medical Premium Liability Dueto Agency
MedicalPremiumLiabilityDuetoAgency
|
729000000 | USD |
CY2016Q2 | moh |
Medical Premium Liability Dueto Agency
MedicalPremiumLiabilityDuetoAgency
|
1238000000 | USD |
CY2013 | moh |
Net Income Loss From Continuing Operations Before Equity Method Investments Extraordinary Items Noncontrolling Interest
NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest
|
45000000 | USD |
CY2014 | moh |
Net Income Loss From Continuing Operations Before Equity Method Investments Extraordinary Items Noncontrolling Interest
NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest
|
62000000 | USD |
CY2015Q2 | moh |
Net Income Loss From Continuing Operations Before Equity Method Investments Extraordinary Items Noncontrolling Interest
NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest
|
39000000 | USD |
moh |
Net Income Loss From Continuing Operations Before Equity Method Investments Extraordinary Items Noncontrolling Interest
NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest
|
67000000 | USD | |
CY2015 | moh |
Net Income Loss From Continuing Operations Before Equity Method Investments Extraordinary Items Noncontrolling Interest
NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest
|
143000000 | USD |
CY2016Q2 | moh |
Net Income Loss From Continuing Operations Before Equity Method Investments Extraordinary Items Noncontrolling Interest
NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest
|
33000000 | USD |
moh |
Net Income Loss From Continuing Operations Before Equity Method Investments Extraordinary Items Noncontrolling Interest
NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest
|
57000000 | USD | |
moh |
Numberof Members Added
NumberofMembersAdded
|
392000 | member | |
CY2013Q4 | moh |
Other Claims Payable
OtherClaimsPayable
|
181000000 | USD |
CY2014Q4 | moh |
Other Claims Payable
OtherClaimsPayable
|
231000000 | USD |
CY2015Q4 | moh |
Other Claims Payable
OtherClaimsPayable
|
266000000 | USD |
CY2016Q2 | moh |
Other Claims Payable
OtherClaimsPayable
|
334000000 | USD |
CY2013 | moh |
Percentage Of Capitation
PercentageOfCapitation
|
0.112 | |
CY2014 | moh |
Percentage Of Capitation
PercentageOfCapitation
|
0.093 | |
CY2015 | moh |
Percentage Of Capitation
PercentageOfCapitation
|
0.083 | |
CY2013 | moh |
Percentage Of Fee For Service
PercentageOfFeeForService
|
0.671 | |
CY2014 | moh |
Percentage Of Fee For Service
PercentageOfFeeForService
|
0.702 | |
CY2015 | moh |
Percentage Of Fee For Service
PercentageOfFeeForService
|
0.727 | |
CY2013 | moh |
Percentage Of Medical Costs
PercentageOfMedicalCosts
|
1 | |
CY2014 | moh |
Percentage Of Medical Costs
PercentageOfMedicalCosts
|
1 | |
CY2015 | moh |
Percentage Of Medical Costs
PercentageOfMedicalCosts
|
1 | |
CY2013 | moh |
Percentage Of Other
PercentageOfOther
|
0.034 | |
CY2014 | moh |
Percentage Of Other
PercentageOfOther
|
0.035 | |
CY2015 | moh |
Percentage Of Other
PercentageOfOther
|
0.042 | |
CY2013 | moh |
Percentage Of Pharmacy
PercentageOfPharmacy
|
0.174 | |
CY2014 | moh |
Percentage Of Pharmacy
PercentageOfPharmacy
|
0.158 | |
CY2015 | moh |
Percentage Of Pharmacy
PercentageOfPharmacy
|
0.137 | |
CY2013 | moh |
Percentof Direct Delivery
PercentofDirectDelivery
|
0.009 | |
CY2014 | moh |
Percentof Direct Delivery
PercentofDirectDelivery
|
0.012 | |
CY2015 | moh |
Percentof Direct Delivery
PercentofDirectDelivery
|
0.011 | |
CY2013Q4 | moh |
Pharmacy Claims Payable
PharmacyClaimsPayable
|
45000000 | USD |
CY2014Q4 | moh |
Pharmacy Claims Payable
PharmacyClaimsPayable
|
71000000 | USD |
CY2015Q4 | moh |
Pharmacy Claims Payable
PharmacyClaimsPayable
|
88000000 | USD |
CY2016Q2 | moh |
Pharmacy Claims Payable
PharmacyClaimsPayable
|
103000000 | USD |
CY2015 | moh |
Policy Holder Benefits Prior Percentage
PolicyHolderBenefitsPriorPercentage
|
0.118 | |
moh |
Policy Holder Benefits Prior Percentage
PolicyHolderBenefitsPriorPercentage
|
0.113 | ||
CY2015 | moh |
Policy Holder Medical Care Cost Prior Year Percentage
PolicyHolderMedicalCareCostPriorYearPercentage
|
0.012 | |
moh |
Policy Holder Medical Care Cost Prior Year Percentage
PolicyHolderMedicalCareCostPriorYearPercentage
|
0.014 | ||
CY2015 | moh |
Policy Holder Premium Revenue Prior Year Percentage
PolicyHolderPremiumRevenuePriorYearPercentage
|
0.011 | |
moh |
Policy Holder Premium Revenue Prior Year Percentage
PolicyHolderPremiumRevenuePriorYearPercentage
|
0.013 | ||
CY2013 | moh |
Premium Tax Expenses
PremiumTaxExpenses
|
172000000 | USD |
CY2014 | moh |
Premium Tax Expenses
PremiumTaxExpenses
|
294000000 | USD |
moh |
Unrecognized Compensation Forfeited Rate
UnrecognizedCompensationForfeitedRate
|
0.043 | ||
CY2015Q2 | moh |
Premium Tax Expenses
PremiumTaxExpenses
|
95000000 | USD |
moh |
Premium Tax Expenses
PremiumTaxExpenses
|
190000000 | USD | |
CY2015 | moh |
Premium Tax Expenses
PremiumTaxExpenses
|
397000000 | USD |
CY2016Q2 | moh |
Premium Tax Expenses
PremiumTaxExpenses
|
109000000 | USD |
moh |
Premium Tax Expenses
PremiumTaxExpenses
|
218000000 | USD | |
CY2015Q2 | moh |
Quality Incentive Premium Revenue As A Percentage Of Total Revenue
QualityIncentivePremiumRevenueAsAPercentageOfTotalRevenue
|
0.007 | |
moh |
Quality Incentive Premium Revenue As A Percentage Of Total Revenue
QualityIncentivePremiumRevenueAsAPercentageOfTotalRevenue
|
0.005 | ||
CY2016Q2 | moh |
Quality Incentive Premium Revenue As A Percentage Of Total Revenue
QualityIncentivePremiumRevenueAsAPercentageOfTotalRevenue
|
0.021 | |
moh |
Quality Incentive Premium Revenue As A Percentage Of Total Revenue
QualityIncentivePremiumRevenueAsAPercentageOfTotalRevenue
|
0.013 | ||
CY2013 | moh |
Retirement Of Treasury Stock
RetirementOfTreasuryStock
|
56000000 | USD |
CY2014 | moh |
Retirement Of Treasury Stock
RetirementOfTreasuryStock
|
0 | USD |
CY2015 | moh |
Retirement Of Treasury Stock
RetirementOfTreasuryStock
|
0 | USD |
CY2015Q4 | moh |
Sharebased Compensation Arrangementby Sharebased Payment Award Numberof Plans
SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofPlans
|
2 | Plan |
CY2015 | moh |
Stock Issued During Period Valueand Income Tax Benefit Relatedto Sharebased Compensation
StockIssuedDuringPeriodValueandIncomeTaxBenefitRelatedtoSharebasedCompensation
|
34000000 | USD |
moh |
Stock Issued During Period Valueand Income Tax Benefit Relatedto Sharebased Compensation
StockIssuedDuringPeriodValueandIncomeTaxBenefitRelatedtoSharebasedCompensation
|
19000000 | USD | |
CY2015 | moh |
Unrecognized Compensation Forfeited Rate
UnrecognizedCompensationForfeitedRate
|
0.065 | |
CY2015Q2 | moh |
Weighted Average Number Of Shares Issued Under Equity Offering
WeightedAverageNumberOfSharesIssuedUnderEquityOffering
|
1000000 | shares |
moh |
Weighted Average Number Of Shares Issued Under Equity Offering
WeightedAverageNumberOfSharesIssuedUnderEquityOffering
|
1000000 | shares | |
CY2016Q2 | moh |
Weighted Average Number Of Shares Issued Under Equity Offering
WeightedAverageNumberOfSharesIssuedUnderEquityOffering
|
0 | shares |
moh |
Weighted Average Number Of Shares Issued Under Equity Offering
WeightedAverageNumberOfSharesIssuedUnderEquityOffering
|
0 | shares | |
CY2013 | moh |
Weighted Average Numberof Shares Issued Exchangeof Debt Instruments
WeightedAverageNumberofSharesIssuedExchangeofDebtInstruments
|
0 | shares |
CY2014 | moh |
Weighted Average Numberof Shares Issued Exchangeof Debt Instruments
WeightedAverageNumberofSharesIssuedExchangeofDebtInstruments
|
1000000 | shares |
CY2015 | moh |
Weighted Average Numberof Shares Issued Exchangeof Debt Instruments
WeightedAverageNumberofSharesIssuedExchangeofDebtInstruments
|
0 | shares |
CY2014Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
242000000 | USD |
CY2015Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
362000000 | USD |
CY2016Q2 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
537000000 | USD |
CY2014Q4 | us-gaap |
Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
|
9000000 | USD |
CY2015Q4 | us-gaap |
Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
|
0 | USD |
CY2014Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
277000000 | USD |
CY2015Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
362000000 | USD |
CY2014Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-1000000 | USD |
CY2015Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-4000000 | USD |
CY2016Q2 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
4000000 | USD |
CY2016Q1 | us-gaap |
Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
|
P5Y11M | |
CY2014Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
396000000 | USD |
CY2015Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
803000000 | USD |
CY2016Q2 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
822000000 | USD |
CY2013 | us-gaap |
Adjustment For Amortization
AdjustmentForAmortization
|
46000000 | USD |
CY2014 | us-gaap |
Adjustment For Amortization
AdjustmentForAmortization
|
59000000 | USD |
CY2015 | us-gaap |
Adjustment For Amortization
AdjustmentForAmortization
|
52000000 | USD |
CY2013 | us-gaap |
Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
|
2000000 | USD |
CY2014 | us-gaap |
Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
|
3000000 | USD |
CY2015 | us-gaap |
Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
|
8000000 | USD |
CY2014 | us-gaap |
Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
|
22000000 | USD |
CY2013 | us-gaap |
Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
|
2000000 | USD |
CY2014 | us-gaap |
Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
|
3000000 | USD |
CY2014Q4 | us-gaap |
Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
2000000 | USD |
CY2015Q4 | us-gaap |
Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
7000000 | USD |
CY2015 | us-gaap |
Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
|
8000000 | USD |
CY2013 | us-gaap |
Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
|
79000000 | USD |
CY2013 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
29000000 | USD |
CY2014 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
22000000 | USD |
CY2015Q2 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
3000000 | USD |
us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
9000000 | USD | |
CY2015 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
23000000 | USD |
CY2016Q2 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
9000000 | USD |
us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
16000000 | USD | |
CY2013 | us-gaap |
Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
|
25000000 | USD |
CY2014 | us-gaap |
Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
|
14000000 | USD |
CY2015 | us-gaap |
Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
|
16000000 | USD |
CY2013 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
22000000 | USD |
CY2014 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
26000000 | USD |
CY2015Q2 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
7000000 | USD |
us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
14000000 | USD | |
CY2015 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
29000000 | USD |
CY2016Q2 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
8000000 | USD |
us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
15000000 | USD | |
CY2013 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
18000000 | USD |
CY2014 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
18000000 | USD |
CY2015 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
17000000 | USD |
CY2014Q4 | us-gaap |
Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries
AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries
|
859000000 | USD |
CY2015Q4 | us-gaap |
Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries
AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries
|
1229000000 | USD |
CY2016Q2 | us-gaap |
Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries
AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries
|
1299000000 | USD |
CY2013Q4 | us-gaap |
Assets
Assets
|
2988000000 | USD |
CY2014Q4 | us-gaap |
Assets
Assets
|
4435000000 | USD |
CY2015Q4 | us-gaap |
Assets
Assets
|
6576000000 | USD |
CY2016Q2 | us-gaap |
Assets
Assets
|
7202000000 | USD |
CY2014Q4 | us-gaap |
Assets Current
AssetsCurrent
|
3203000000 | USD |
CY2015Q4 | us-gaap |
Assets Current
AssetsCurrent
|
5306000000 | USD |
CY2016Q2 | us-gaap |
Assets Current
AssetsCurrent
|
5545000000 | USD |
CY2014Q4 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
1021000000 | USD |
CY2015Q4 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
1808000000 | USD |
CY2016Q2 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
1961000000 | USD |
CY2014Q4 | us-gaap |
Available For Sale Securities
AvailableForSaleSecurities
|
1019000000 | USD |
CY2015Q4 | us-gaap |
Available For Sale Securities
AvailableForSaleSecurities
|
1801000000 | USD |
CY2016Q2 | us-gaap |
Available For Sale Securities
AvailableForSaleSecurities
|
1968000000 | USD |
CY2014Q4 | us-gaap |
Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
0 | USD |
CY2015Q4 | us-gaap |
Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
0 | USD |
CY2016Q2 | us-gaap |
Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
7000000 | USD |
CY2016Q2 | us-gaap |
Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
0 | USD |
CY2014Q4 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
|
1000000 | USD |
CY2015Q4 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
|
6000000 | USD |
CY2014Q4 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
|
540000000 | USD |
CY2015Q4 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
|
1296000000 | USD |
CY2015Q4 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
|
1000000 | USD |
CY2014Q4 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
|
1000000 | USD |
CY2015Q4 | us-gaap |
Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
|
11000000 | USD |
CY2013 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
140000000 | USD |
CY2014Q4 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
|
43000000 | USD |
CY2015Q4 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
|
124000000 | USD |
CY2015Q4 | us-gaap |
Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Greater Than Or Equal To One Year
AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear
|
99 | Security |
CY2015Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
2329000000 | USD |
CY2015Q4 | us-gaap |
Capital Leases Future Minimum Payments Receivable
CapitalLeasesFutureMinimumPaymentsReceivable
|
17000000 | USD |
CY2015Q4 | us-gaap |
Capital Leases Future Minimum Payments Receivable Current
CapitalLeasesFutureMinimumPaymentsReceivableCurrent
|
4000000 | USD |
CY2015Q4 | us-gaap |
Capital Leases Future Minimum Payments Receivable Due Thereafter
CapitalLeasesFutureMinimumPaymentsReceivableDueThereafter
|
1000000 | USD |
CY2015Q4 | us-gaap |
Capital Leases Future Minimum Payments Receivable In Five Years
CapitalLeasesFutureMinimumPaymentsReceivableInFiveYears
|
2000000 | USD |
CY2015Q4 | us-gaap |
Capital Leases Future Minimum Payments Receivable In Four Years
CapitalLeasesFutureMinimumPaymentsReceivableInFourYears
|
2000000 | USD |
CY2015Q4 | us-gaap |
Capital Leases Future Minimum Payments Receivable In Three Years
CapitalLeasesFutureMinimumPaymentsReceivableInThreeYears
|
4000000 | USD |
CY2016Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
2345000000 | USD |
CY2016Q2 | us-gaap |
Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
|
33000000 | USD |
CY2015Q4 | us-gaap |
Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
|
10000000 | USD |
CY2016Q2 | us-gaap |
Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
|
34000000 | USD |
CY2015Q4 | us-gaap |
Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
|
967000000 | USD |
CY2016Q2 | us-gaap |
Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
|
844000000 | USD |
CY2015Q4 | us-gaap |
Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
|
962000000 | USD |
CY2016Q2 | us-gaap |
Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
|
850000000 | USD |
CY2015Q4 | us-gaap |
Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
|
830000000 | USD |
CY2016Q2 | us-gaap |
Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
|
1084000000 | USD |
CY2015Q4 | us-gaap |
Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
|
829000000 | USD |
CY2016Q2 | us-gaap |
Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
|
1084000000 | USD |
CY2015Q4 | us-gaap |
Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
|
1801000000 | USD |
CY2016Q2 | us-gaap |
Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
|
1968000000 | USD |
CY2014Q4 | us-gaap |
Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Less Than One Year
AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear
|
416 | Security |
CY2015Q4 | us-gaap |
Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Less Than One Year
AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear
|
1143 | Security |
CY2014Q4 | us-gaap |
Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Greater Than Or Equal To One Year
AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear
|
26 | Security |
CY2015Q4 | us-gaap |
Capital Leases Future Minimum Payments Receivable In Two Years
CapitalLeasesFutureMinimumPaymentsReceivableInTwoYears
|
4000000 | USD |
CY2014Q4 | us-gaap |
Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
|
148000000 | USD |
CY2015Q4 | us-gaap |
Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
|
195000000 | USD |
CY2012Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
796000000 | USD |
CY2013Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
936000000 | USD |
CY2014Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1539000000 | USD |
CY2015Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
2014000000 | USD |
CY2014 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
603000000 | USD |
us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
475000000 | USD | |
CY2015 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
790000000 | USD |
us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
16000000 | USD | |
CY2013Q4 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
53.8475 | |
CY2015Q4 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
53.8475 | |
CY2014Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2015Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2016Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2014Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
150000000 | shares |
CY2015Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
150000000 | shares |
CY2016Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
150000000 | shares |
CY2014Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
50000000 | shares |
CY2013 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
52000000 | USD |
CY2015Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
56000000 | shares |
CY2016Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
57000000 | shares |
CY2014Q4 | us-gaap |
Common Stock Value Outstanding
CommonStockValueOutstanding
|
0 | USD |
CY2015Q4 | us-gaap |
Common Stock Value Outstanding
CommonStockValueOutstanding
|
0 | USD |
CY2016Q2 | us-gaap |
Common Stock Value Outstanding
CommonStockValueOutstanding
|
0 | USD |
CY2014 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
62000000 | USD |
CY2015Q2 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
37000000 | USD |
us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
66000000 | USD | |
CY2015 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
140000000 | USD |
CY2016Q2 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
35000000 | USD |
us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
65000000 | USD | |
CY2013 | us-gaap |
Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
|
27000000 | USD |
CY2014 | us-gaap |
Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
|
14000000 | USD |
CY2015 | us-gaap |
Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
|
0 | USD |
CY2014Q4 | us-gaap |
Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
|
690000000 | USD |
CY2015Q4 | us-gaap |
Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
|
962000000 | USD |
CY2016Q2 | us-gaap |
Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
|
1428000000 | USD |
CY2013 | us-gaap |
Cost Of Goods Sold Depreciation And Amortization
CostOfGoodsSoldDepreciationAndAmortization
|
94000000 | USD |
CY2014 | us-gaap |
Cost Of Goods Sold Depreciation And Amortization
CostOfGoodsSoldDepreciationAndAmortization
|
134000000 | USD |
CY2015 | us-gaap |
Cost Of Goods Sold Depreciation And Amortization
CostOfGoodsSoldDepreciationAndAmortization
|
126000000 | USD |
CY2013 | us-gaap |
Cost Of Services Amortization
CostOfServicesAmortization
|
3000000 | USD |
CY2014 | us-gaap |
Cost Of Services Amortization
CostOfServicesAmortization
|
3000000 | USD |
CY2015 | us-gaap |
Cost Of Services Amortization
CostOfServicesAmortization
|
1000000 | USD |
CY2013 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
6452000000 | USD |
CY2014 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
9474000000 | USD |
CY2015Q2 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
3409000000 | USD |
us-gaap |
Costs And Expenses
CostsAndExpenses
|
6498000000 | USD | |
CY2015 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
13791000000 | USD |
CY2016Q2 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
4254000000 | USD |
us-gaap |
Costs And Expenses
CostsAndExpenses
|
8508000000 | USD | |
CY2014Q4 | us-gaap |
Costs In Excess Of Billings On Uncompleted Contracts Or Programs Expected To Be Collected After One Year
CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedAfterOneYear
|
54000000 | USD |
CY2015Q4 | us-gaap |
Costs In Excess Of Billings On Uncompleted Contracts Or Programs Expected To Be Collected After One Year
CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedAfterOneYear
|
81000000 | USD |
CY2016Q2 | us-gaap |
Costs In Excess Of Billings On Uncompleted Contracts Or Programs Expected To Be Collected After One Year
CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedAfterOneYear
|
80000000 | USD |
CY2013 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
67000000 | USD |
CY2014 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
72000000 | USD |
CY2015 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
172000000 | USD |
CY2013 | us-gaap |
Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
|
0 | USD |
CY2014 | us-gaap |
Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
|
0 | USD |
CY2015 | us-gaap |
Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
|
6000000 | USD |
CY2013 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
67000000 | USD |
CY2014 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
75000000 | USD |
CY2015 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
186000000 | USD |
CY2013 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
0 | USD |
CY2014 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
3000000 | USD |
CY2015 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
8000000 | USD |
CY2013 | us-gaap |
Debt Conversion Converted Instrument Warrants Or Options Issued1
DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1
|
13490236 | shares |
CY2015 | us-gaap |
Debt Conversion Converted Instrument Warrants Or Options Issued1
DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1
|
13490236 | shares |
CY2014Q4 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
852000000 | USD |
CY2015Q4 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
1553000000 | USD |
CY2016Q2 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
1552000000 | USD |
CY2014Q4 | us-gaap |
Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
|
148000000 | USD |
CY2015Q4 | us-gaap |
Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
|
120000000 | USD |
CY2016Q2 | us-gaap |
Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
|
104000000 | USD |
CY2015Q4 | us-gaap |
Decrease In Unrecognized Tax Benefits Is Reasonably Possible
DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
|
1000000 | USD |
CY2013 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
-25000000 | USD |
CY2014 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
0 | USD |
CY2015 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
-10000000 | USD |
CY2014Q4 | us-gaap |
Deferred Finance Costs Net
DeferredFinanceCostsNet
|
14000000 | USD |
CY2015Q4 | us-gaap |
Deferred Finance Costs Net
DeferredFinanceCostsNet
|
22000000 | USD |
CY2016Q2 | us-gaap |
Deferred Finance Costs Net
DeferredFinanceCostsNet
|
20000000 | USD |
CY2013 | us-gaap |
Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
|
0 | USD |
CY2014 | us-gaap |
Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
|
0 | USD |
CY2015 | us-gaap |
Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
|
-1000000 | USD |
CY2013 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-31000000 | USD |
CY2014 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-2000000 | USD |
CY2015 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-7000000 | USD |
CY2014Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
78000000 | USD |
CY2015Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
110000000 | USD |
CY2014Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
196000000 | USD |
CY2015Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
223000000 | USD |
CY2016Q2 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
104000000 | USD |
CY2013 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
-6000000 | USD |
CY2014 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
-2000000 | USD |
CY2015 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
4000000 | USD |
CY2014Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
15000000 | USD |
CY2015Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
18000000 | USD |
CY2014Q4 | us-gaap |
Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
|
15000000 | USD |
CY2015Q4 | us-gaap |
Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
|
18000000 | USD |
CY2016Q2 | us-gaap |
Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
|
0 | USD |
CY2014Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
93000000 | USD |
CY2015Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
128000000 | USD |
CY2014Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
3000000 | USD |
CY2015Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
7000000 | USD |
CY2014Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
|
8000000 | USD |
CY2015Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
|
8000000 | USD |
CY2014Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
|
4000000 | USD |
CY2015Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
|
5000000 | USD |
CY2014Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
|
10000000 | USD |
CY2015Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
|
8000000 | USD |
CY2014Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
|
13000000 | USD |
CY2015Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
|
37000000 | USD |
CY2014Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent
|
34000000 | USD |
CY2015Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent
|
35000000 | USD |
CY2014Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
|
4000000 | USD |
CY2015Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
|
14000000 | USD |
CY2014Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Unearned Premiums Reserve
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve
|
22000000 | USD |
CY2015Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Unearned Premiums Reserve
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve
|
21000000 | USD |
CY2014Q4 | us-gaap |
Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross
DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross
|
1000000 | USD |
CY2015Q4 | us-gaap |
Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross
DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross
|
2000000 | USD |
CY2014Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
6000000 | USD |
CY2015Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
9000000 | USD |
CY2014Q4 | us-gaap |
Deferred Tax Liabilities Financing Arrangements
DeferredTaxLiabilitiesFinancingArrangements
|
15000000 | USD |
CY2015Q4 | us-gaap |
Deferred Tax Liabilities Financing Arrangements
DeferredTaxLiabilitiesFinancingArrangements
|
18000000 | USD |
CY2015Q4 | us-gaap |
Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
|
0 | USD |
CY2016Q2 | us-gaap |
Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
|
25000000 | USD |
CY2014Q4 | us-gaap |
Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
|
6000000 | USD |
CY2015Q4 | us-gaap |
Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
|
9000000 | USD |
CY2014Q4 | us-gaap |
Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
|
57000000 | USD |
CY2015Q4 | us-gaap |
Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
|
83000000 | USD |
CY2013 | us-gaap |
Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
|
13000000 | USD |
CY2014 | us-gaap |
Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
|
21000000 | USD |
CY2015 | us-gaap |
Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
|
27000000 | USD |
CY2015 | us-gaap |
Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
|
0.04 | |
CY2013 | us-gaap |
Depreciation
Depreciation
|
27000000 | USD |
CY2014 | us-gaap |
Depreciation
Depreciation
|
35000000 | USD |
CY2015 | us-gaap |
Depreciation
Depreciation
|
49000000 | USD |
CY2013 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
73000000 | USD |
CY2014 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
93000000 | USD |
CY2015Q2 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
25000000 | USD |
us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
50000000 | USD | |
CY2015 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
104000000 | USD |
CY2016Q2 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
34000000 | USD |
us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
66000000 | USD | |
CY2013 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
94000000 | USD |
CY2014 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
134000000 | USD |
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
62000000 | USD | |
CY2015 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
126000000 | USD |
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
89000000 | USD | |
CY2014Q4 | us-gaap |
Derivative Assets Current
DerivativeAssetsCurrent
|
0 | USD |
CY2015Q4 | us-gaap |
Derivative Assets Current
DerivativeAssetsCurrent
|
374000000 | USD |
CY2016Q2 | us-gaap |
Derivative Assets Current
DerivativeAssetsCurrent
|
0 | USD |
CY2014Q4 | us-gaap |
Derivative Assets Noncurrent
DerivativeAssetsNoncurrent
|
329000000 | USD |
CY2015Q4 | us-gaap |
Derivative Assets Noncurrent
DerivativeAssetsNoncurrent
|
0 | USD |
CY2016Q2 | us-gaap |
Derivative Assets Noncurrent
DerivativeAssetsNoncurrent
|
226000000 | USD |
CY2013 | us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
-4000000 | USD |
CY2014 | us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
0 | USD |
us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
0 | USD | |
CY2015 | us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
0 | USD |
us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
0 | USD | |
CY2014Q4 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
0 | USD |
CY2015Q4 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
374000000 | USD |
CY2016Q2 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
0 | USD |
CY2014Q4 | us-gaap |
Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
|
329000000 | USD |
CY2015Q4 | us-gaap |
Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
|
0 | USD |
CY2016Q2 | us-gaap |
Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
|
226000000 | USD |
CY2013 | us-gaap |
Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation
DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation
|
-10000000 | USD |
CY2014 | us-gaap |
Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation
DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation
|
0 | USD |
CY2015 | us-gaap |
Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation
DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation
|
0 | USD |
CY2014Q4 | us-gaap |
Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
|
40000000 | USD |
CY2015Q4 | us-gaap |
Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
|
0 | USD |
CY2013 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
1.16 | |
CY2014Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.10 | |
CY2014Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.17 | |
CY2014Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.34 | |
CY2014Q4 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.70 | |
CY2014 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
1.33 | |
CY2015Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.58 | |
CY2015Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.78 | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
1.36 | ||
CY2015Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.84 | |
CY2015Q4 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.54 | |
CY2015 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
2.75 | |
CY2016Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.58 | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
1.02 | ||
CY2013 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
1.13 | |
CY2014Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.09 | |
CY2014Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.16 | |
CY2014Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.33 | |
CY2014Q4 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.69 | |
CY2014 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
1.29 | |
CY2015Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.56 | |
CY2015Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.72 | |
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
1.29 | ||
CY2015Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.77 | |
CY2015Q4 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.52 | |
CY2015 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
2.58 | |
CY2016Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.58 | |
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
1.01 | ||
CY2013 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.448 | |
CY2014 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.538 | |
CY2015 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.555 | |
CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.35 | |
CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.35 | |
CY2015 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.35 | |
CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
|
0.096 | |
CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
|
-0.041 | |
CY2015 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
|
0.006 | |
CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
0.020 | |
CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
-0.003 | |
CY2015 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
-0.004 | |
CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
-0.005 | |
CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.004 | |
CY2015 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.024 | |
CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Contingencies
EffectiveIncomeTaxRateReconciliationTaxContingencies
|
-0.037 | |
CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Contingencies
EffectiveIncomeTaxRateReconciliationTaxContingencies
|
-0.001 | |
CY2015 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Contingencies
EffectiveIncomeTaxRateReconciliationTaxContingencies
|
0.009 | |
CY2015Q4 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
25000000 | USD |
CY2016Q2 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
45000000 | USD |
CY2015 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P1Y7M | |
us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P1Y9M | ||
CY2014Q4 | us-gaap |
Fair Value Concentration Of Risk Investments
FairValueConcentrationOfRiskInvestments
|
321000000 | USD |
CY2015Q4 | us-gaap |
Fair Value Concentration Of Risk Investments
FairValueConcentrationOfRiskInvestments
|
605000000 | USD |
CY2013 | us-gaap |
Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
|
122000000 | USD |
CY2014 | us-gaap |
Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
|
52000000 | USD |
us-gaap |
Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
|
0 | USD | |
CY2015 | us-gaap |
Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
|
389000000 | USD |
us-gaap |
Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
|
131000000 | USD | |
CY2014Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
160000000 | USD |
CY2015Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
178000000 | USD |
CY2015Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
|
25000000 | USD |
CY2015Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
|
13000000 | USD |
CY2015Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
|
18000000 | USD |
CY2015Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
22000000 | USD |
CY2015Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
25000000 | USD |
CY2014Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
249000000 | USD |
CY2015Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
300000000 | USD |
CY2014Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
89000000 | USD |
CY2015Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
122000000 | USD |
CY2016Q2 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
146000000 | USD |
CY2015 | us-gaap |
Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
|
51000000 | USD |
CY2016Q1 | us-gaap |
Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
|
34000000 | USD |
CY2013 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
666000000 | USD |
CY2014 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
765000000 | USD |
CY2015Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
287000000 | USD |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
543000000 | USD | |
CY2015 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1146000000 | USD |
CY2016Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
351000000 | USD |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
691000000 | USD | |
CY2014Q4 | us-gaap |
Goodwill
Goodwill
|
272000000 | USD |
CY2015Q4 | us-gaap |
Goodwill
Goodwill
|
519000000 | USD |
CY2016Q2 | us-gaap |
Goodwill
Goodwill
|
611000000 | USD |
CY2016Q1 | us-gaap |
Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
|
90000000 | USD |
CY2014Q4 | us-gaap |
Goodwill Gross
GoodwillGross
|
330000000 | USD |
CY2015Q2 | us-gaap |
Health Care Organization Other Revenue
HealthCareOrganizationOtherRevenue
|
1000000 | USD |
CY2014 | us-gaap |
Health Care Organization Premium Revenue
HealthCareOrganizationPremiumRevenue
|
9023000000 | USD |
CY2015Q1 | us-gaap |
Health Care Organization Premium Revenue
HealthCareOrganizationPremiumRevenue
|
2971000000 | USD |
CY2015Q2 | us-gaap |
Health Care Organization Premium Revenue
HealthCareOrganizationPremiumRevenue
|
3304000000 | USD |
us-gaap |
Health Care Organization Other Revenue
HealthCareOrganizationOtherRevenue
|
3000000 | USD | |
CY2015 | us-gaap |
Health Care Organization Other Revenue
HealthCareOrganizationOtherRevenue
|
5000000 | USD |
CY2016Q2 | us-gaap |
Health Care Organization Other Revenue
HealthCareOrganizationOtherRevenue
|
2000000 | USD |
us-gaap |
Health Care Organization Other Revenue
HealthCareOrganizationOtherRevenue
|
3000000 | USD | |
CY2013 | us-gaap |
Health Care Organization Premium Revenue
HealthCareOrganizationPremiumRevenue
|
6179000000 | USD |
CY2014Q1 | us-gaap |
Health Care Organization Premium Revenue
HealthCareOrganizationPremiumRevenue
|
1940000000 | USD |
CY2014Q2 | us-gaap |
Health Care Organization Premium Revenue
HealthCareOrganizationPremiumRevenue
|
2167000000 | USD |
CY2014Q3 | us-gaap |
Health Care Organization Premium Revenue
HealthCareOrganizationPremiumRevenue
|
2317000000 | USD |
CY2014Q4 | us-gaap |
Health Care Organization Premium Revenue
HealthCareOrganizationPremiumRevenue
|
2599000000 | USD |
CY2015Q4 | us-gaap |
Goodwill Gross
GoodwillGross
|
577000000 | USD |
CY2014Q4 | us-gaap |
Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
|
58000000 | USD |
CY2015Q4 | us-gaap |
Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
|
58000000 | USD |
CY2013 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
0 | USD |
CY2014 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
0 | USD |
CY2015 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
0 | USD |
CY2013 | us-gaap |
Gross Profit
GrossProfit
|
843000000 | USD |
CY2014 | us-gaap |
Gross Profit
GrossProfit
|
1000000000 | USD |
CY2015Q2 | us-gaap |
Gross Profit
GrossProfit
|
389000000 | USD |
us-gaap |
Gross Profit
GrossProfit
|
740000000 | USD | |
CY2015 | us-gaap |
Gross Profit
GrossProfit
|
1507000000 | USD |
CY2016Q2 | us-gaap |
Gross Profit
GrossProfit
|
454000000 | USD |
us-gaap |
Gross Profit
GrossProfit
|
874000000 | USD | |
CY2013 | us-gaap |
Health Care Organization Health Care Costs Gross
HealthCareOrganizationHealthCareCostsGross
|
5380000000 | USD |
CY2014 | us-gaap |
Health Care Organization Health Care Costs Gross
HealthCareOrganizationHealthCareCostsGross
|
8076000000 | USD |
CY2015 | us-gaap |
Health Care Organization Health Care Costs Gross
HealthCareOrganizationHealthCareCostsGross
|
11794000000 | USD |
CY2013 | us-gaap |
Health Care Organization Medical Supplies And Drugs Expense
HealthCareOrganizationMedicalSuppliesAndDrugsExpense
|
935000000 | USD |
CY2014 | us-gaap |
Health Care Organization Medical Supplies And Drugs Expense
HealthCareOrganizationMedicalSuppliesAndDrugsExpense
|
1273000000 | USD |
CY2015 | us-gaap |
Health Care Organization Medical Supplies And Drugs Expense
HealthCareOrganizationMedicalSuppliesAndDrugsExpense
|
1610000000 | USD |
CY2013 | us-gaap |
Health Care Organization Other Revenue
HealthCareOrganizationOtherRevenue
|
26000000 | USD |
CY2014 | us-gaap |
Health Care Organization Other Revenue
HealthCareOrganizationOtherRevenue
|
12000000 | USD |
us-gaap |
Health Care Organization Premium Revenue
HealthCareOrganizationPremiumRevenue
|
6275000000 | USD | |
CY2015Q3 | us-gaap |
Health Care Organization Premium Revenue
HealthCareOrganizationPremiumRevenue
|
3377000000 | USD |
CY2015Q4 | us-gaap |
Health Care Organization Premium Revenue
HealthCareOrganizationPremiumRevenue
|
3589000000 | USD |
CY2015 | us-gaap |
Health Care Organization Premium Revenue
HealthCareOrganizationPremiumRevenue
|
13241000000 | USD |
CY2016Q2 | us-gaap |
Health Care Organization Premium Revenue
HealthCareOrganizationPremiumRevenue
|
4029000000 | USD |
us-gaap |
Health Care Organization Premium Revenue
HealthCareOrganizationPremiumRevenue
|
8024000000 | USD | |
CY2015Q4 | us-gaap |
Held To Maturity Securities
HeldToMaturitySecurities
|
109000000 | USD |
CY2016Q2 | us-gaap |
Held To Maturity Securities
HeldToMaturitySecurities
|
107000000 | USD |
CY2015Q4 | us-gaap |
Held To Maturity Securities Debt Maturities After One Through Five Years Fair Value
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
|
9000000 | USD |
CY2016Q2 | us-gaap |
Held To Maturity Securities Debt Maturities After One Through Five Years Fair Value
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
|
1000000 | USD |
CY2015Q4 | us-gaap |
Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount
|
9000000 | USD |
CY2016Q2 | us-gaap |
Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount
|
1000000 | USD |
CY2014Q4 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
34000000 | USD |
CY2015Q4 | us-gaap |
Held To Maturity Securities Debt Maturities Within One Year Fair Value
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue
|
100000000 | USD |
CY2016Q2 | us-gaap |
Held To Maturity Securities Debt Maturities Within One Year Fair Value
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue
|
106000000 | USD |
CY2015Q4 | us-gaap |
Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
|
100000000 | USD |
CY2016Q2 | us-gaap |
Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
|
106000000 | USD |
CY2015Q4 | us-gaap |
Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
|
109000000 | USD |
CY2016Q2 | us-gaap |
Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
|
107000000 | USD |
CY2013 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
45000000 | USD |
CY2014Q1 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
4000000 | USD |
CY2014Q2 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
8000000 | USD |
CY2014Q3 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
16000000 | USD |
CY2014 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
62000000 | USD |
CY2015Q1 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
28000000 | USD |
CY2015Q2 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
39000000 | USD |
CY2015Q3 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
46000000 | USD |
CY2015Q4 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
30000000 | USD |
CY2015 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
143000000 | USD |
CY2013 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
81000000 | USD |
CY2014 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
135000000 | USD |
CY2015Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
101000000 | USD |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
168000000 | USD | |
CY2015 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
322000000 | USD |
CY2016Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
80000000 | USD |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
144000000 | USD | |
CY2013 | us-gaap |
Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
|
0.98 | |
CY2014 | us-gaap |
Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
|
1.34 | |
CY2015 | us-gaap |
Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
|
2.75 | |
CY2013 | us-gaap |
Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
|
0.96 | |
CY2014 | us-gaap |
Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
|
1.30 | |
CY2015 | us-gaap |
Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
|
2.58 | |
CY2013 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
|
8000000 | USD |
CY2014 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
|
0 | USD |
CY2015 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
|
0 | USD |
CY2013 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
|
0.18 | |
CY2014 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
|
-0.01 | |
CY2015 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
|
0.00 | |
CY2013 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
|
0.17 | |
CY2014 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
|
-0.01 | |
CY2015 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
|
0.00 | |
CY2013 | us-gaap |
Income Loss From Subsidiaries Net Of Tax
IncomeLossFromSubsidiariesNetOfTax
|
0 | USD |
CY2014 | us-gaap |
Income Loss From Subsidiaries Net Of Tax
IncomeLossFromSubsidiariesNetOfTax
|
0 | USD |
CY2015Q2 | us-gaap |
Income Loss From Subsidiaries Net Of Tax
IncomeLossFromSubsidiariesNetOfTax
|
0 | USD |
us-gaap |
Income Loss From Subsidiaries Net Of Tax
IncomeLossFromSubsidiariesNetOfTax
|
0 | USD | |
CY2015 | us-gaap |
Income Loss From Subsidiaries Net Of Tax
IncomeLossFromSubsidiariesNetOfTax
|
0 | USD |
CY2016Q2 | us-gaap |
Income Loss From Subsidiaries Net Of Tax
IncomeLossFromSubsidiariesNetOfTax
|
0 | USD |
us-gaap |
Income Loss From Subsidiaries Net Of Tax
IncomeLossFromSubsidiariesNetOfTax
|
0 | USD | |
CY2013 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-20000000 | USD |
CY2014 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
74000000 | USD |
us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-138000000 | USD | |
CY2015 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
24000000 | USD |
CY2013 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
36000000 | USD |
CY2014 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
73000000 | USD |
CY2015Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
62000000 | USD |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
101000000 | USD | |
CY2015 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
179000000 | USD |
CY2016Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
47000000 | USD |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
87000000 | USD | |
CY2013 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
95000000 | USD |
CY2014 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
30000000 | USD |
CY2015 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
197000000 | USD |
CY2014Q4 | us-gaap |
Income Taxes Receivable
IncomeTaxesReceivable
|
0 | USD |
CY2015Q4 | us-gaap |
Income Taxes Receivable
IncomeTaxesReceivable
|
13000000 | USD |
CY2016Q2 | us-gaap |
Income Taxes Receivable
IncomeTaxesReceivable
|
23000000 | USD |
CY2013 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
33000000 | USD |
CY2014 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
11000000 | USD |
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
158000000 | USD | |
CY2015 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
84000000 | USD |
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
147000000 | USD | |
CY2013 | us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
-39000000 | USD |
CY2014 | us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
42000000 | USD |
us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
1000000 | USD | |
CY2015 | us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
-22000000 | USD |
us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
-10000000 | USD | |
CY2013 | us-gaap |
Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
|
32000000 | USD |
CY2014 | us-gaap |
Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
|
2000000 | USD |
us-gaap |
Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
|
-7000000 | USD | |
CY2015 | us-gaap |
Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
|
7000000 | USD |
us-gaap |
Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
|
-39000000 | USD | |
us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-119000000 | USD | |
CY2013 | us-gaap |
Increase Decrease In Health Care Insurance Liabilities
IncreaseDecreaseInHealthCareInsuranceLiabilities
|
175000000 | USD |
CY2014 | us-gaap |
Increase Decrease In Health Care Insurance Liabilities
IncreaseDecreaseInHealthCareInsuranceLiabilities
|
531000000 | USD |
us-gaap |
Increase Decrease In Health Care Insurance Liabilities
IncreaseDecreaseInHealthCareInsuranceLiabilities
|
292000000 | USD | |
CY2015 | us-gaap |
Increase Decrease In Health Care Insurance Liabilities
IncreaseDecreaseInHealthCareInsuranceLiabilities
|
482000000 | USD |
us-gaap |
Increase Decrease In Health Care Insurance Liabilities
IncreaseDecreaseInHealthCareInsuranceLiabilities
|
82000000 | USD | |
CY2013 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
23000000 | USD |
CY2014 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
20000000 | USD |
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
97000000 | USD | |
CY2015 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
35000000 | USD |
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
143000000 | USD | |
CY2013 | us-gaap |
Increase Decrease In Receivables
IncreaseDecreaseInReceivables
|
149000000 | USD |
CY2014 | us-gaap |
Increase Decrease In Receivables
IncreaseDecreaseInReceivables
|
298000000 | USD |
us-gaap |
Increase Decrease In Receivables
IncreaseDecreaseInReceivables
|
35000000 | USD | |
CY2015 | us-gaap |
Increase Decrease In Receivables
IncreaseDecreaseInReceivables
|
-56000000 | USD |
us-gaap |
Increase Decrease In Receivables
IncreaseDecreaseInReceivables
|
415000000 | USD | |
CY2013 | us-gaap |
Increase Decrease Of Restricted Investments
IncreaseDecreaseOfRestrictedInvestments
|
19000000 | USD |
CY2014 | us-gaap |
Increase Decrease Of Restricted Investments
IncreaseDecreaseOfRestrictedInvestments
|
34000000 | USD |
us-gaap |
Increase Decrease Of Restricted Investments
IncreaseDecreaseOfRestrictedInvestments
|
14000000 | USD | |
CY2015 | us-gaap |
Increase Decrease Of Restricted Investments
IncreaseDecreaseOfRestrictedInvestments
|
6000000 | USD |
us-gaap |
Increase Decrease Of Restricted Investments
IncreaseDecreaseOfRestrictedInvestments
|
-5000000 | USD | |
CY2013 | us-gaap |
Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
|
0 | shares |
CY2014 | us-gaap |
Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
|
0 | shares |
CY2015Q2 | us-gaap |
Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
|
3000000 | shares |
us-gaap |
Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
|
2000000 | shares | |
CY2015 | us-gaap |
Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
|
2000000 | shares |
CY2016Q2 | us-gaap |
Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
|
0 | shares |
us-gaap |
Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
|
1000000 | shares | |
CY2013 | us-gaap |
Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
|
0 | shares |
CY2014 | us-gaap |
Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
|
1000000 | shares |
CY2015Q2 | us-gaap |
Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
|
1000000 | shares |
us-gaap |
Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
|
0 | shares | |
CY2015 | us-gaap |
Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
|
1000000 | shares |
CY2016Q2 | us-gaap |
Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
|
0 | shares |
us-gaap |
Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
|
0 | shares | |
CY2013 | us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
1000000 | shares |
CY2014 | us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
0 | shares |
CY2015 | us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
1000000 | shares |
CY2014Q4 | us-gaap |
Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
|
361000000 | USD |
CY2015Q4 | us-gaap |
Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
|
641000000 | USD |
CY2013 | us-gaap |
Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
|
7000000 | USD |
CY2014 | us-gaap |
Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
|
8000000 | USD |
CY2015Q2 | us-gaap |
Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
|
4000000 | USD |
us-gaap |
Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
|
7000000 | USD | |
CY2015 | us-gaap |
Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
|
18000000 | USD |
CY2016Q2 | us-gaap |
Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
|
8000000 | USD |
us-gaap |
Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
|
16000000 | USD | |
CY2013 | us-gaap |
Interest Expense
InterestExpense
|
52000000 | USD |
CY2014 | us-gaap |
Interest Expense
InterestExpense
|
57000000 | USD |
CY2015Q2 | us-gaap |
Interest Expense
InterestExpense
|
15000000 | USD |
us-gaap |
Interest Expense
InterestExpense
|
30000000 | USD | |
CY2015 | us-gaap |
Interest Expense
InterestExpense
|
66000000 | USD |
CY2016Q2 | us-gaap |
Interest Expense
InterestExpense
|
25000000 | USD |
us-gaap |
Interest Expense
InterestExpense
|
50000000 | USD | |
CY2013 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
35000000 | USD |
CY2014 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
39000000 | USD |
CY2015Q2 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
10000000 | USD |
us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
20000000 | USD | |
CY2015 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
46000000 | USD |
CY2016Q2 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
11000000 | USD |
us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
21000000 | USD | |
CY2013 | us-gaap |
Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
|
13000000 | USD |
CY2014 | us-gaap |
Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
|
13000000 | USD |
CY2015Q2 | us-gaap |
Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
|
3000000 | USD |
us-gaap |
Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
|
6000000 | USD | |
CY2013 | us-gaap |
Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
|
5381000000 | USD |
CY2014 | us-gaap |
Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
|
8077000000 | USD |
CY2015 | us-gaap |
Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
|
11794000000 | USD |
us-gaap |
Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
|
7182000000 | USD | |
CY2015 | us-gaap |
Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
|
17000000 | USD |
CY2016Q2 | us-gaap |
Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
|
3000000 | USD |
us-gaap |
Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
|
6000000 | USD | |
CY2013 | us-gaap |
Interest Paid
InterestPaid
|
35000000 | USD |
CY2014 | us-gaap |
Interest Paid
InterestPaid
|
29000000 | USD |
CY2015 | us-gaap |
Interest Paid
InterestPaid
|
38000000 | USD |
CY2014Q4 | us-gaap |
Investments In And Advances To Affiliates Amount Of Equity
InvestmentsInAndAdvancesToAffiliatesAmountOfEquity
|
0 | USD |
CY2015Q4 | us-gaap |
Investments In And Advances To Affiliates Amount Of Equity
InvestmentsInAndAdvancesToAffiliatesAmountOfEquity
|
0 | USD |
CY2016Q2 | us-gaap |
Investments In And Advances To Affiliates Amount Of Equity
InvestmentsInAndAdvancesToAffiliatesAmountOfEquity
|
0 | USD |
CY2014Q4 | us-gaap |
Liabilities
Liabilities
|
3425000000 | USD |
CY2015Q4 | us-gaap |
Liabilities
Liabilities
|
5019000000 | USD |
CY2016Q2 | us-gaap |
Liabilities
Liabilities
|
5561000000 | USD |
CY2014Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
4435000000 | USD |
CY2015Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
6576000000 | USD |
CY2016Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
7202000000 | USD |
CY2013 | us-gaap |
Liabilities Assumed1
LiabilitiesAssumed1
|
0 | USD |
CY2014 | us-gaap |
Liabilities Assumed1
LiabilitiesAssumed1
|
0 | USD |
CY2015 | us-gaap |
Liabilities Assumed1
LiabilitiesAssumed1
|
41000000 | USD |
CY2014Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
2175000000 | USD |
CY2015Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
3822000000 | USD |
CY2016Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
3646000000 | USD |
CY2012Q4 | us-gaap |
Liability For Claims And Claims Adjustment Expense
LiabilityForClaimsAndClaimsAdjustmentExpense
|
495000000 | USD |
CY2013Q4 | us-gaap |
Liability For Claims And Claims Adjustment Expense
LiabilityForClaimsAndClaimsAdjustmentExpense
|
670000000 | USD |
CY2014Q4 | us-gaap |
Liability For Claims And Claims Adjustment Expense
LiabilityForClaimsAndClaimsAdjustmentExpense
|
1201000000 | USD |
CY2015Q4 | us-gaap |
Liability For Claims And Claims Adjustment Expense
LiabilityForClaimsAndClaimsAdjustmentExpense
|
1685000000 | USD |
CY2016Q2 | us-gaap |
Liability For Claims And Claims Adjustment Expense
LiabilityForClaimsAndClaimsAdjustmentExpense
|
1766000000 | USD |
CY2013 | us-gaap |
Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year1
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
|
4932000000 | USD |
CY2014 | us-gaap |
Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year1
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
|
7064000000 | USD |
CY2015 | us-gaap |
Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year1
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
|
10448000000 | USD |
us-gaap |
Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year1
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
|
5885000000 | USD | |
CY2013 | us-gaap |
Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
|
385000000 | USD |
CY2014 | us-gaap |
Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
|
450000000 | USD |
CY2015 | us-gaap |
Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
|
910000000 | USD |
us-gaap |
Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
|
1240000000 | USD | |
CY2013Q4 | us-gaap |
Liability For Unpaid Claims And Claims Adjustment Expense Incurred But Not Reported Ibnr Claims Amount
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount
|
424000000 | USD |
CY2014Q4 | us-gaap |
Liability For Unpaid Claims And Claims Adjustment Expense Incurred But Not Reported Ibnr Claims Amount
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount
|
871000000 | USD |
CY2015Q4 | us-gaap |
Liability For Unpaid Claims And Claims Adjustment Expense Incurred But Not Reported Ibnr Claims Amount
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount
|
1191000000 | USD |
CY2016Q2 | us-gaap |
Liability For Unpaid Claims And Claims Adjustment Expense Incurred But Not Reported Ibnr Claims Amount
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount
|
1292000000 | USD |
CY2014Q4 | us-gaap |
Long Term Debt
LongTermDebt
|
690000000 | USD |
CY2015Q4 | us-gaap |
Long Term Debt
LongTermDebt
|
1411000000 | USD |
CY2016Q2 | us-gaap |
Long Term Debt
LongTermDebt
|
1428000000 | USD |
CY2014Q4 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
0 | USD |
CY2015Q4 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
449000000 | USD |
CY2016Q2 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
1000000 | USD |
CY2015Q4 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
|
1000000 | USD |
CY2015Q4 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
|
550000000 | USD |
CY2016Q2 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
|
550000000 | USD |
CY2015Q4 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
|
0 | USD |
CY2016Q2 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
|
0 | USD |
CY2015Q4 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
|
0 | USD |
CY2016Q2 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
|
0 | USD |
CY2015Q4 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
|
0 | USD |
CY2016Q2 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
|
0 | USD |
CY2015Q4 | us-gaap |
Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
|
1002000000 | USD |
CY2016Q2 | us-gaap |
Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
|
1002000000 | USD |
CY2016Q2 | us-gaap |
Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
|
0 | USD |
CY2014Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
887000000 | USD |
CY2015Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
1160000000 | USD |
CY2016Q2 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
1626000000 | USD |
CY2014Q4 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
1019000000 | USD |
CY2015Q4 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
1801000000 | USD |
CY2016Q2 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
1968000000 | USD |
CY2013 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
493000000 | USD |
CY2014 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
79000000 | USD |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
384000000 | USD | |
CY2015 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
1085000000 | USD |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
11000000 | USD | |
CY2013 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-543000000 | USD |
CY2014 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-536000000 | USD |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-557000000 | USD | |
CY2015 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-1420000000 | USD |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-273000000 | USD | |
CY2013 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
190000000 | USD |
CY2014 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
1060000000 | USD |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
648000000 | USD | |
CY2015 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
1125000000 | USD |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
278000000 | USD | |
CY2013 | us-gaap |
Net Income Loss
NetIncomeLoss
|
53000000 | USD |
CY2014Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
4000000 | USD |
CY2014Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
8000000 | USD |
CY2014Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
16000000 | USD |
CY2014Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
34000000 | USD |
CY2014 | us-gaap |
Net Income Loss
NetIncomeLoss
|
62000000 | USD |
CY2015Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
28000000 | USD |
CY2015Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
39000000 | USD |
us-gaap |
Net Income Loss
NetIncomeLoss
|
67000000 | USD | |
CY2015Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
46000000 | USD |
CY2015Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
30000000 | USD |
CY2015 | us-gaap |
Net Income Loss
NetIncomeLoss
|
143000000 | USD |
CY2016Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
33000000 | USD |
us-gaap |
Net Income Loss
NetIncomeLoss
|
57000000 | USD | |
us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
8000000 | USD | |
CY2015Q2 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
15000000 | USD |
CY2013 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-56000000 | USD |
CY2014 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-58000000 | USD |
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
30000000 | USD | |
CY2015 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-65000000 | USD |
CY2016Q2 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
25000000 | USD |
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
50000000 | USD | |
CY2013 | us-gaap |
Notes Issued1
NotesIssued1
|
0 | USD |
CY2014 | us-gaap |
Notes Issued1
NotesIssued1
|
177000000 | USD |
CY2015 | us-gaap |
Notes Issued1
NotesIssued1
|
0 | USD |
CY2015 | us-gaap |
Number Of Reportable Segments
NumberOfReportableSegments
|
3 | Segment |
us-gaap |
Number Of Reportable Segments
NumberOfReportableSegments
|
3 | Segment | |
CY2013 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
137000000 | USD |
CY2014Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
24000000 | USD |
CY2014Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
32000000 | USD |
CY2014Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
40000000 | USD |
CY2014Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
97000000 | USD |
CY2014 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
193000000 | USD |
CY2015Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
82000000 | USD |
CY2015Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
116000000 | USD |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
198000000 | USD | |
CY2015Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
113000000 | USD |
CY2015Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
76000000 | USD |
CY2015 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
387000000 | USD |
CY2016Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
105000000 | USD |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
194000000 | USD | |
CY2015Q4 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
635000000 | USD |
CY2015Q4 | us-gaap |
Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
|
64000000 | USD |
CY2015Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
|
41000000 | USD |
CY2015Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
|
48000000 | USD |
CY2015Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
|
57000000 | USD |
CY2015Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
|
63000000 | USD |
CY2015Q4 | us-gaap |
Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
|
362000000 | USD |
CY2013 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
25000000 | USD |
CY2014 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
32000000 | USD |
CY2015 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
44000000 | USD |
CY2014Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
30000000 | USD |
CY2015Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
28000000 | USD |
CY2016Q2 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
39000000 | USD |
CY2013 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-1000000 | USD |
CY2014 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
0 | USD |
CY2015Q2 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-2000000 | USD |
us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-1000000 | USD | |
CY2015 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-3000000 | USD |
CY2016Q2 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
2000000 | USD |
us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
8000000 | USD | |
CY2013 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
|
-1000000 | USD |
CY2014 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
|
0 | USD |
CY2015Q2 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
|
-3000000 | USD |
us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
|
-1000000 | USD | |
CY2015 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
|
-5000000 | USD |
CY2016Q2 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
|
4000000 | USD |
us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
|
13000000 | USD | |
CY2013 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
|
0 | USD |
CY2014 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
|
0 | USD |
CY2015Q2 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
|
-1000000 | USD |
us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
|
0 | USD | |
CY2015 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
|
-2000000 | USD |
CY2016Q2 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
|
2000000 | USD |
us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
|
5000000 | USD | |
CY2014Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
34000000 | USD |
CY2015Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
37000000 | USD |
CY2016Q2 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
38000000 | USD |
CY2013 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-4000000 | USD |
CY2014 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-1000000 | USD |
CY2015 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
1000000 | USD |
CY2013 | us-gaap |
Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
|
18000000 | USD |
CY2014 | us-gaap |
Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
|
7000000 | USD |
us-gaap |
Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
|
9000000 | USD | |
CY2015 | us-gaap |
Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
|
19000000 | USD |
us-gaap |
Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
|
11000000 | USD | |
CY2013 | us-gaap |
Payments For Derivative Instrument Financing Activities
PaymentsForDerivativeInstrumentFinancingActivities
|
149000000 | USD |
CY2014 | us-gaap |
Payments For Derivative Instrument Financing Activities
PaymentsForDerivativeInstrumentFinancingActivities
|
0 | USD |
CY2015 | us-gaap |
Payments For Derivative Instrument Financing Activities
PaymentsForDerivativeInstrumentFinancingActivities
|
0 | USD |
CY2013 | us-gaap |
Payments For Losses And Loss Adjustment Expense
PaymentsForLossesAndLossAdjustmentExpense
|
5317000000 | USD |
CY2014 | us-gaap |
Payments For Losses And Loss Adjustment Expense
PaymentsForLossesAndLossAdjustmentExpense
|
7514000000 | USD |
CY2015 | us-gaap |
Payments For Losses And Loss Adjustment Expense
PaymentsForLossesAndLossAdjustmentExpense
|
11358000000 | USD |
us-gaap |
Payments For Losses And Loss Adjustment Expense
PaymentsForLossesAndLossAdjustmentExpense
|
7125000000 | USD | |
CY2013 | us-gaap |
Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
|
-6000000 | USD |
CY2014 | us-gaap |
Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
|
23000000 | USD |
us-gaap |
Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
|
17000000 | USD | |
CY2015 | us-gaap |
Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
|
35000000 | USD |
us-gaap |
Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
|
6000000 | USD | |
CY2013 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
53000000 | USD |
CY2014 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
0 | USD |
CY2015 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
0 | USD |
CY2013 | us-gaap |
Payments To Acquire Additional Interest In Subsidiaries
PaymentsToAcquireAdditionalInterestInSubsidiaries
|
0 | USD |
CY2014 | us-gaap |
Payments To Acquire Additional Interest In Subsidiaries
PaymentsToAcquireAdditionalInterestInSubsidiaries
|
0 | USD |
us-gaap |
Payments To Acquire Additional Interest In Subsidiaries
PaymentsToAcquireAdditionalInterestInSubsidiaries
|
0 | USD | |
CY2015 | us-gaap |
Payments To Acquire Additional Interest In Subsidiaries
PaymentsToAcquireAdditionalInterestInSubsidiaries
|
0 | USD |
us-gaap |
Payments To Acquire Additional Interest In Subsidiaries
PaymentsToAcquireAdditionalInterestInSubsidiaries
|
0 | USD | |
CY2013 | us-gaap |
Payments To Acquire Business Two Net Of Cash Acquired
PaymentsToAcquireBusinessTwoNetOfCashAcquired
|
0 | USD |
CY2014 | us-gaap |
Payments To Acquire Business Two Net Of Cash Acquired
PaymentsToAcquireBusinessTwoNetOfCashAcquired
|
50000000 | USD |
CY2015 | us-gaap |
Payments To Acquire Business Two Net Of Cash Acquired
PaymentsToAcquireBusinessTwoNetOfCashAcquired
|
0 | USD |
CY2013 | us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
62000000 | USD |
CY2013 | us-gaap |
Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
|
98000000 | USD |
CY2014 | us-gaap |
Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
|
115000000 | USD |
us-gaap |
Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
|
66000000 | USD | |
CY2015 | us-gaap |
Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
|
132000000 | USD |
us-gaap |
Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
|
102000000 | USD | |
CY2014 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
953000000 | USD |
us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
993000000 | USD | |
CY2015 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
1923000000 | USD |
us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
974000000 | USD | |
CY2013 | us-gaap |
Policyholder Benefits And Claims Incurred Health Care
PolicyholderBenefitsAndClaimsIncurredHealthCare
|
5380000000 | USD |
CY2014 | us-gaap |
Policyholder Benefits And Claims Incurred Health Care
PolicyholderBenefitsAndClaimsIncurredHealthCare
|
8076000000 | USD |
CY2015Q2 | us-gaap |
Policyholder Benefits And Claims Incurred Health Care
PolicyholderBenefitsAndClaimsIncurredHealthCare
|
2929000000 | USD |
CY2013 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
770000000 | USD |
us-gaap |
Policyholder Benefits And Claims Incurred Health Care
PolicyholderBenefitsAndClaimsIncurredHealthCare
|
5565000000 | USD | |
CY2015 | us-gaap |
Policyholder Benefits And Claims Incurred Health Care
PolicyholderBenefitsAndClaimsIncurredHealthCare
|
11794000000 | USD |
CY2016Q2 | us-gaap |
Policyholder Benefits And Claims Incurred Health Care
PolicyholderBenefitsAndClaimsIncurredHealthCare
|
3594000000 | USD |
us-gaap |
Policyholder Benefits And Claims Incurred Health Care
PolicyholderBenefitsAndClaimsIncurredHealthCare
|
7182000000 | USD | |
CY2014Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2015Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2016Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2014 | us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
44000000 | USD |
us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
8000000 | USD | |
CY2015 | us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
450000000 | USD |
CY2014 | us-gaap |
Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
|
0 | USD |
CY2015 | us-gaap |
Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
|
0 | USD |
CY2013 | us-gaap |
Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
|
2000000 | USD |
CY2014 | us-gaap |
Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
|
2000000 | USD |
CY2014Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
20000000 | shares |
CY2015Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
20000000 | shares |
CY2016Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
20000000 | shares |
CY2014Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2015Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2016Q2 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2014Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2015Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2016Q2 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2014Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
CY2015Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
CY2016Q2 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
CY2014Q4 | us-gaap |
Premiums Receivable Gross
PremiumsReceivableGross
|
0 | USD |
CY2015Q4 | us-gaap |
Premiums Receivable Gross
PremiumsReceivableGross
|
3000000 | USD |
CY2016Q2 | us-gaap |
Premiums Receivable Gross
PremiumsReceivableGross
|
1000000 | USD |
CY2014Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
49000000 | USD |
CY2015Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
192000000 | USD |
CY2016Q2 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
197000000 | USD |
CY2013 | us-gaap |
Proceeds From Dividends Received
ProceedsFromDividendsReceived
|
0 | USD |
us-gaap |
Proceeds From Dividends Received
ProceedsFromDividendsReceived
|
0 | USD | |
CY2015 | us-gaap |
Proceeds From Dividends Received
ProceedsFromDividendsReceived
|
0 | USD |
us-gaap |
Proceeds From Dividends Received
ProceedsFromDividendsReceived
|
0 | USD | |
CY2015Q2 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
373000000 | USD |
CY2013 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
0 | USD |
CY2014 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
0 | USD |
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
373000000 | USD | |
CY2015 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
373000000 | USD |
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
0 | USD | |
CY2013 | us-gaap |
Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
|
538000000 | USD |
CY2014 | us-gaap |
Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
|
123000000 | USD |
CY2015 | us-gaap |
Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
|
689000000 | USD |
CY2013 | us-gaap |
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
|
9000000 | USD |
CY2014 | us-gaap |
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
|
14000000 | USD |
CY2013 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
29000000 | USD |
CY2014 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
22000000 | USD |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
9000000 | USD | |
CY2015Q4 | us-gaap |
Restricted Investments Noncurrent
RestrictedInvestmentsNoncurrent
|
109000000 | USD |
CY2016Q2 | us-gaap |
Restricted Investments Noncurrent
RestrictedInvestmentsNoncurrent
|
107000000 | USD |
CY2014Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
615000000 | USD |
CY2015Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
758000000 | USD |
CY2015 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
23000000 | USD |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
16000000 | USD | |
CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
377000 | shares |
CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
|
22000000 | USD |
CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
|
39000000 | USD |
CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
0 | shares |
CY2016Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
815000000 | USD |
CY2013 | us-gaap |
Revenues
Revenues
|
6589000000 | USD |
us-gaap |
Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
|
3000000 | USD | |
CY2014 | us-gaap |
Revenues
Revenues
|
9667000000 | USD |
CY2015Q2 | us-gaap |
Revenues
Revenues
|
3525000000 | USD |
us-gaap |
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
|
8000000 | USD | |
CY2015 | us-gaap |
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
|
18000000 | USD |
us-gaap |
Revenues
Revenues
|
6696000000 | USD | |
CY2015 | us-gaap |
Revenues
Revenues
|
14178000000 | USD |
CY2016Q2 | us-gaap |
Revenues
Revenues
|
4359000000 | USD |
us-gaap |
Revenues
Revenues
|
8702000000 | USD | |
CY2013 | us-gaap |
Sale Leaseback Transaction Gross Proceeds Financing Activities
SaleLeasebackTransactionGrossProceedsFinancingActivities
|
159000000 | USD |
CY2014 | us-gaap |
Sale Leaseback Transaction Gross Proceeds Financing Activities
SaleLeasebackTransactionGrossProceedsFinancingActivities
|
0 | USD |
CY2015 | us-gaap |
Sale Leaseback Transaction Gross Proceeds Financing Activities
SaleLeasebackTransactionGrossProceedsFinancingActivities
|
0 | USD |
us-gaap |
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
|
10000000 | USD | |
CY2013 | us-gaap |
Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
|
75000000 | USD |
CY2015 | us-gaap |
Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
|
5000000 | USD |
us-gaap |
Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
|
1000000 | USD | |
CY2013 | us-gaap |
Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
|
0 | USD |
CY2014 | us-gaap |
Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
|
0 | USD |
us-gaap |
Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
|
0 | USD | |
CY2015 | us-gaap |
Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
|
0 | USD |
us-gaap |
Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
|
0 | USD | |
CY2013 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
400000000 | USD |
CY2014 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
633000000 | USD |
us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
541000000 | USD | |
CY2015 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
1126000000 | USD |
us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
812000000 | USD | |
CY2014Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
618000000 | USD |
CY2015Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
755000000 | USD |
CY2014Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
341000000 | USD |
CY2015Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
393000000 | USD |
CY2016Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
448000000 | USD |
CY2014Q4 | us-gaap |
Property Plant And Equipment Owned Accumulated Depreciation
PropertyPlantAndEquipmentOwnedAccumulatedDepreciation
|
129000000 | USD |
CY2015Q4 | us-gaap |
Property Plant And Equipment Owned Accumulated Depreciation
PropertyPlantAndEquipmentOwnedAccumulatedDepreciation
|
167000000 | USD |
CY2014Q4 | us-gaap |
Receivables Net Current
ReceivablesNetCurrent
|
596000000 | USD |
CY2015Q4 | us-gaap |
Receivables Net Current
ReceivablesNetCurrent
|
597000000 | USD |
CY2016Q2 | us-gaap |
Receivables Net Current
ReceivablesNetCurrent
|
1012000000 | USD |
CY2014Q4 | us-gaap |
Related Party Transaction Due From To Related Party Current
RelatedPartyTransactionDueFromToRelatedPartyCurrent
|
0 | USD |
CY2015Q4 | us-gaap |
Related Party Transaction Due From To Related Party Current
RelatedPartyTransactionDueFromToRelatedPartyCurrent
|
0 | USD |
CY2016Q2 | us-gaap |
Related Party Transaction Due From To Related Party Current
RelatedPartyTransactionDueFromToRelatedPartyCurrent
|
0 | USD |
CY2013 | us-gaap |
Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
|
0 | USD |
CY2014 | us-gaap |
Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
|
10000000 | USD |
CY2015 | us-gaap |
Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
|
0 | USD |
CY2013 | us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
48000000 | USD |
CY2014 | us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
0 | USD |
CY2015 | us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
0 | USD |
CY2013 | us-gaap |
Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
|
40000000 | USD |
CY2014 | us-gaap |
Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
|
0 | USD |
CY2015 | us-gaap |
Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
|
0 | USD |
CY2014Q4 | us-gaap |
Restricted Investments Noncurrent
RestrictedInvestmentsNoncurrent
|
102000000 | USD |
CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
0 | shares |
CY2012Q4 | us-gaap |
Shares Outstanding
SharesOutstanding
|
47000000 | shares |
CY2013Q4 | us-gaap |
Shares Outstanding
SharesOutstanding
|
46000000 | shares |
CY2014Q4 | us-gaap |
Shares Outstanding
SharesOutstanding
|
49000000 | shares |
CY2015Q1 | us-gaap |
Shares Outstanding
SharesOutstanding
|
49000000 | shares |
CY2015Q4 | us-gaap |
Shares Outstanding
SharesOutstanding
|
55000000 | shares |
CY2016Q1 | us-gaap |
Shares Outstanding
SharesOutstanding
|
55000000 | shares |
CY2015Q4 | us-gaap |
Statutory Accounting Practices Statutory Capital And Surplus Balance
StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance
|
1350000000 | USD |
CY2016Q2 | us-gaap |
Statutory Accounting Practices Statutory Capital And Surplus Balance
StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance
|
1384000000 | USD |
CY2015Q4 | us-gaap |
Statutory Accounting Practices Statutory Capital And Surplus Required
StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired
|
776000000 | USD |
CY2016Q2 | us-gaap |
Statutory Accounting Practices Statutory Capital And Surplus Required
StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired
|
854000000 | USD |
CY2013 | us-gaap |
Stock Issued1
StockIssued1
|
8000000 | USD |
CY2014 | us-gaap |
Stock Issued1
StockIssued1
|
9000000 | USD |
us-gaap |
Stock Issued1
StockIssued1
|
9000000 | USD | |
CY2015 | us-gaap |
Stock Issued1
StockIssued1
|
15000000 | USD |
us-gaap |
Stock Issued1
StockIssued1
|
7000000 | USD | |
CY2015 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
373000000 | USD |
CY2013 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
31000000 | USD |
CY2014 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
30000000 | USD |
CY2015 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
26000000 | USD |
CY2014Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1010000000 | USD |
CY2015Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1557000000 | USD |
CY2016Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1641000000 | USD |
CY2012Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
782000000 | USD |
CY2013Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
893000000 | USD |
CY2014Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
1010000000 | USD |
CY2015Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
1557000000 | USD |
CY2015 | us-gaap |
Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
|
547000000 | USD |
us-gaap |
Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
|
84000000 | USD | |
CY2013 | us-gaap |
Supplemental Deferred Purchase Price
SupplementalDeferredPurchasePrice
|
0 | USD |
CY2014 | us-gaap |
Supplemental Deferred Purchase Price
SupplementalDeferredPurchasePrice
|
8000000 | USD |
us-gaap |
Supplemental Deferred Purchase Price
SupplementalDeferredPurchasePrice
|
-8000000 | USD | |
CY2015 | us-gaap |
Supplemental Deferred Purchase Price
SupplementalDeferredPurchasePrice
|
0 | USD |
us-gaap |
Supplemental Deferred Purchase Price
SupplementalDeferredPurchasePrice
|
21000000 | USD | |
CY2013 | us-gaap |
Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense
SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
|
5434000000 | USD |
CY2014 | us-gaap |
Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense
SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
|
8123000000 | USD |
CY2015 | us-gaap |
Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense
SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
|
11935000000 | USD |
us-gaap |
Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense
SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
|
7371000000 | USD | |
CY2013 | us-gaap |
Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense
SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
|
-53000000 | USD |
CY2014 | us-gaap |
Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense
SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
|
-46000000 | USD |
CY2015 | us-gaap |
Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense
SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
|
-141000000 | USD |
us-gaap |
Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense
SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
|
-189000000 | USD | |
CY2015Q4 | us-gaap |
Tax Credit Carryforward Valuation Allowance
TaxCreditCarryforwardValuationAllowance
|
9000000 | USD |
CY2013 | us-gaap |
Technology Services Costs
TechnologyServicesCosts
|
161000000 | USD |
CY2014 | us-gaap |
Technology Services Costs
TechnologyServicesCosts
|
157000000 | USD |
CY2015Q2 | us-gaap |
Technology Services Costs
TechnologyServicesCosts
|
33000000 | USD |
us-gaap |
Technology Services Costs
TechnologyServicesCosts
|
69000000 | USD | |
CY2015 | us-gaap |
Technology Services Costs
TechnologyServicesCosts
|
193000000 | USD |
CY2016Q2 | us-gaap |
Technology Services Costs
TechnologyServicesCosts
|
116000000 | USD |
us-gaap |
Technology Services Costs
TechnologyServicesCosts
|
243000000 | USD | |
CY2013 | us-gaap |
Technology Services Revenue
TechnologyServicesRevenue
|
205000000 | USD |
CY2014Q1 | us-gaap |
Technology Services Revenue
TechnologyServicesRevenue
|
54000000 | USD |
CY2014Q2 | us-gaap |
Technology Services Revenue
TechnologyServicesRevenue
|
50000000 | USD |
CY2014Q3 | us-gaap |
Technology Services Revenue
TechnologyServicesRevenue
|
52000000 | USD |
CY2014Q4 | us-gaap |
Technology Services Revenue
TechnologyServicesRevenue
|
54000000 | USD |
CY2014 | us-gaap |
Technology Services Revenue
TechnologyServicesRevenue
|
210000000 | USD |
CY2015Q1 | us-gaap |
Technology Services Revenue
TechnologyServicesRevenue
|
52000000 | USD |
CY2015Q2 | us-gaap |
Technology Services Revenue
TechnologyServicesRevenue
|
47000000 | USD |
us-gaap |
Technology Services Revenue
TechnologyServicesRevenue
|
99000000 | USD | |
CY2015Q3 | us-gaap |
Technology Services Revenue
TechnologyServicesRevenue
|
47000000 | USD |
CY2015Q4 | us-gaap |
Technology Services Revenue
TechnologyServicesRevenue
|
107000000 | USD |
CY2015 | us-gaap |
Technology Services Revenue
TechnologyServicesRevenue
|
253000000 | USD |
CY2016Q2 | us-gaap |
Technology Services Revenue
TechnologyServicesRevenue
|
135000000 | USD |
us-gaap |
Technology Services Revenue
TechnologyServicesRevenue
|
275000000 | USD | |
CY2013 | us-gaap |
Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
|
0 | USD |
CY2013 | us-gaap |
Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
|
53000000 | USD |
CY2012Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
11000000 | USD |
CY2013Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
8000000 | USD |
CY2014Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
3000000 | USD |
CY2015Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
9000000 | USD |
CY2013 | us-gaap |
Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
|
5000000 | USD |
CY2014 | us-gaap |
Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
|
0 | USD |
CY2015 | us-gaap |
Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
|
0 | USD |
CY2013 | us-gaap |
Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
|
0 | USD |
CY2014 | us-gaap |
Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
|
6000000 | USD |
CY2015 | us-gaap |
Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
|
0 | USD |
CY2013 | us-gaap |
Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
|
0 | USD |
CY2014 | us-gaap |
Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
|
0 | USD |
CY2015 | us-gaap |
Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
|
1000000 | USD |
CY2013 | us-gaap |
Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
|
2000000 | USD |
CY2014 | us-gaap |
Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
|
1000000 | USD |
CY2015 | us-gaap |
Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
|
5000000 | USD |
CY2013Q4 | us-gaap |
Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
|
6000000 | USD |
CY2014Q4 | us-gaap |
Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
|
2000000 | USD |
CY2015Q4 | us-gaap |
Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
|
7000000 | USD |
CY2015 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
-3000000 | USD |
CY2013 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
47000000 | shares |
CY2014 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
48000000 | shares |
CY2015Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
54000000 | shares |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
52000000 | shares | |
CY2015 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
56000000 | shares |
CY2016Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
55000000 | shares |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
56000000 | shares | |
CY2013 | us-gaap |
Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
|
1000000 | shares |
CY2014 | us-gaap |
Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
|
0 | shares |
CY2015 | us-gaap |
Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
|
0 | shares |
CY2013 | us-gaap |
Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
|
0 | shares |
CY2014 | us-gaap |
Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
|
0 | shares |
CY2015 | us-gaap |
Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
|
3000000 | shares |
CY2013 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
46000000 | shares |
CY2014 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
47000000 | shares |
CY2015Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
50000000 | shares |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
50000000 | shares | |
CY2015 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
52000000 | shares |
CY2016Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
55000000 | shares |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
55000000 | shares | |
CY2015 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentrations of Credit Risk</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash and cash equivalents, investments, receivables, and restricted investments. We invest a substantial portion of our cash in the PFM Funds Prime Series — Institutional Class, and the PFM Funds Government Series. These funds represent a portfolio of highly liquid money market securities that are managed by PFM Asset Management LLC (PFM), a Virginia business trust registered as an open-end management investment fund. As of </font><font style="font-family:inherit;font-size:10pt;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;">, our investments with PFM amounted to approximately </font><font style="font-family:inherit;font-size:10pt;">$605 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$321 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. Our investments and a portion of our cash equivalents are managed by professional portfolio managers operating under documented investment guidelines. Our portfolio managers must obtain our prior approval before selling investments where the loss position of those investments exceeds certain levels. Our investments consist primarily of investment-grade debt securities with a maximum maturity of </font><font style="font-family:inherit;font-size:10pt;">10</font><font style="font-family:inherit;font-size:10pt;"> years and an average duration of </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> years or less. Restricted investments are invested principally in certificates of deposit and U.S. treasury securities. Concentration of credit risk with respect to accounts receivable is limited because our payors consist principally of the governments of each state in which our health plan subsidiaries operate.</font></div></div> | |
us-gaap |
Schedule Of Liability For Unpaid Claims And Claims Adjustment Expense
ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense
|
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table provides the details of our medical claims and benefits payable (including amounts payable for the provision of long-term services and supports, or LTSS) as of the dates indicated.</font></div><div style="line-height:120%;padding-top:8px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31,<br clear="none"/>2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fee-for-service claims incurred but not paid (IBNP)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,292</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,191</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pharmacy payable</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">103</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capitation payable</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">140</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">334</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">266</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,766</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,685</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> | ||
CY2015 | us-gaap |
Schedule Of Liability For Unpaid Claims And Claims Adjustment Expense
ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense
|
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table provides the details of our medical claims and benefits payable (including amounts payable for the provision of long-term services and supports, or LTSS) as of the dates indicated.</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:59%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fee-for-service claims incurred but not paid (IBNP)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,191</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">871</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">424</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pharmacy payable</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capitation payable</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">140</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">266</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">231</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">181</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,685</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,201</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">670</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> | |
CY2015 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities. Estimates also affect the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Principal areas requiring the use of estimates include:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The determination of medical claims and benefits payable of our Health Plans segment;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Health plan contractual provisions that may limit revenue recognition based upon the costs incurred or the profits realized under a specific contract;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Health plan quality incentives that allow us to recognize incremental revenue if certain quality standards are met;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Molina Medicaid Solutions segment revenue and cost recognition;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Settlements under risk or savings sharing programs;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The assessment of deferred contract costs, deferred revenue, long-lived and intangible assets, and goodwill for impairment;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The determination of professional and general liability claims, and reserves for potential absorption of claims unpaid by insolvent providers;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The determination of reserves for the outcome of litigation;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The determination of valuation allowances for deferred tax assets; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The determination of unrecognized tax benefits.</font></div></td></tr></table></div> |